Section 11

EurekaMag PDF full texts Chapter 10,041


Gargett, C.E.; Zaitseva, M.; Bucak, K.; Chu, S.; Fuller, P.J.; Rogers, P.A.W. 2002: 17Beta-estradiol up-regulates vascular endothelial growth factor receptor-2 expression in human myometrial microvascular endothelial cells: role of estrogen receptor-alpha and -beta. Journal of Clinical Endocrinology and Metabolism 87(9): 4341-4349
Campbell, S.E.; Mehan, K.A.; Tunstall, R.J.; Febbraio, M.A.; Cameron-Smith, D. 2003: 17beta-estradiol upregulates the expression of peroxisome proliferator-activated receptor alpha and lipid oxidative genes in skeletal muscle. Journal of Molecular Endocrinology 31(1): 37-45
Richardson, M.A.; Berg, D.T.; Calnek, D.S.; Ciaccia, A.V.; Joyce, D.E.; Grinnell, B.W. 2000: 17beta-estradiol, but not raloxifene, decreases thrombomodulin in the antithrombotic protein C pathway. Endocrinology 141(10): 3908-3911
Finking, G.; Krauss, N.; Römer, S.; Eckert, S.; Lenz, C.; Kamenz, J.; Menke, A.; Brehme, U.; Hombach, V.; Hanke, H. 2001: 17beta-estradiol, gender independently, reduces atheroma development but not neointimal proliferation after balloon injury in the rabbit aorta. Atherosclerosis 154(1): 39-49
Cairoli, F.; Vigo, D.; Battocchio, M.; Faustini, M.; Veronesi, M.C.; Maffeo, G. 2002: 17beta-estradiol, progesterone and testosterone concentrations in cystic fluids and response to GnRH treatment after emptying of ovarian cysts in dairy cows. Reproduction in Domestic Animals 37(5): 294-298
Kanda, N.; Watanabe, S. 2001: 17beta-estradiol, progesterone, and dihydrotestosterone suppress the growth of human melanoma by inhibiting interleukin-8 production. Journal of Investigative Dermatology 117(2): 274-283
Chieffi, P.; Kisslinger, A.; Sinisi, A.A.; Abbondanza, C.; Tramontano, D. 2003: 17beta-estradiol-induced activation of ERK1/2 through endogenous androgen receptor-estradiol receptor alpha-Src complex in human prostate cells. International Journal of Oncology 23(3): 797-801
Mendonca, B.B.; Arnhold, I.J.; Bloise, W.; Andersson, S.; Russell, D.W.; Wilson, J.D. 1999: 17Beta-hydroxysteroid dehydrogenase 3 deficiency in women. Journal of Clinical Endocrinology and Metabolism 84(2): 802-804
Lanisnik Rizner, T.; Stojan, J.; Adamski, J. 2001: 17beta-hydroxysteroid dehydrogenase from the fungus Cochliobolus lunatus: structural and functional aspects. Chemico-Biological Interactions: 130-132(1-3): 793-803
Suzuki, T.; Moriya, T.; Ariga, N.; Kaneko, C.; Kanazawa, M.; Sasano, H. 2000: 17Beta-hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters. British Journal of Cancer 82(3): 518-523
Green, V.L.; Speirs, V.; Landolt, A.M.; Foy, P.M.; Atkin, S.L. 1999: 17Beta-hydroxysteroid dehydrogenase type 1, 2, 3, and 4 expression and enzyme activity in human anterior pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 84(4): 1340-1345
Napoli, J.L. 2001: 17beta-Hydroxysteroid dehydrogenase type 9 and other short-chain dehydrogenases/reductases that catalyze retinoid, 17beta- and 3alpha-hydroxysteroid metabolism. Molecular and Cellular Endocrinology 171(1-2): 103-109
Boehmer, A.L.; Brinkmann, A.O.; Sandkuijl, L.A.; Halley, D.J.; Niermeijer, M.F.; Andersson, S.; de Jong, F.H.; Kayserili, H.; de Vroede, M.A.; Otten, B.J.; Rouwé, C.W.; Mendonça, B.B.; Rodrigues, C.; Bode, H.H.; de Ruiter, P.E.; Delemarre-van de Waal, H.A.; Drop, S.L. 1999: 17Beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. Journal of Clinical Endocrinology and Metabolism 84(12): 4713-4721
Miettinen, M.; Mustonen, M.; Poutanen, M.; Isomaa, V.; Wickman, M.; Söderqvist, G.; Vihko, R.; Vihko, P. 1999: 17Beta-hydroxysteroid dehydrogenases in normal human mammary epithelial cells and breast tissue. Breast Cancer Research and Treatment 57(2): 175-182
Perret, S.; Dockery, P.; Harvey, B.J. 2001: 17beta-oestradiol stimulates capacitative Ca2+ entry in human endometrial cells. Molecular and Cellular Endocrinology 176(1-2): 77-84
Watson, N.; Dunlop, L.; Robson, L.; Sharma, P.; Smith, A. 2000: 17p- syndrome arising from a novel dicentric translocation in a patient with acute myeloid leukemia. Cancer Genetics and Cytogenetics 118(2): 159-162
Morerio, C.; Russo, I.; Rosanda, C.; Rapella, A.; Leszl, A.; Basso, G.; Maserati, E.; Pasquali, F.; Panarello, C. 2001: 17q21-qter trisomy is an indicator of poor prognosis in acute myelogenous leukemia. Cancer Genetics and Cytogenetics 124(1): 12-15
Wu, G.J.; Sinclair, C.S.; Paape, J.; Ingle, J.N.; Roche, P.C.; James, C.D.; Couch, F.J. 2000: 17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGma1B genes. Cancer Research 60(19): 5371-5375
Korean-Division-Of-The-International-Association-For-Dental-Research 1999: 17th Annual Academic Session of the Korean Division of the International Association for Dental Research (Seoul, Korea; January 22-23, 1999). Journal of Dental Research 78(5): 1139-1149
Belgian Society, O.Cardiology 1999: 17th Annual Scientific Sessions of the Working Group on Cardiac Pacing and Electrophysiology of the Belgian Society of Cardiology, Mont-Godinne, Belgium, September 3, 1998. Acta Cardiologica 54(4): 231-242
Association-Of-French-Speaking-Diatomists 1999: 17th Colloquium of the Association of French Speaking Diatomists (Luxembourg; September 8-11, 1998). Cryptogamie Algologie 20(2): 105-148
Anonymous 2001: 17th Continuing Education Congress: Progress in Allergology, Immunology and Dermatology, Davos, Switzerland, September 12-15, 2001. Allergologie 24(8): 349-358
Chauhan, O.S.; Suneethi, J. 2001: 18 Ka BP records of climatic changes, Bay of Bengal: Isotopic and sedimentological evidences. Current Science 81(9): 1231-1234
Yang-Jing; Peng-Ren-Xiu; Yu-Jie-Ping 2001: 18 alpha-glycyrrhizic acid down-regulated the activities and mRNA expression of cytochrome P450 isoenzymes in rat hepatocyte sandwich cultures. Zhongguo Yaolixue Yu Dulixue Zazhi 15(2): 155-158
Umeda, I.O.; Kashiwa, Y.; Nishigori, H. 2001: 18 kDa protein tyrosine phosphatase in the ocular lens. Experimental Eye Research 73(1): 123-132
Stas, M.; Stroobants, S.; Dupont, P.; Gysen, M.; Hoe, L.V.; Garmyn, M.; Mortelmans, L.; Wever, I.D. 2002: 18-FDG PET scan in the staging of recurrent melanoma: additional value and therapeutic impact. Melanoma Research 12(5): 479-490
Franke, C.; Klapdor, R.; Meyerhoff, K.; Schauman, M. 1999: 18-FDG positron emission tomography of the pancreas: diagnostic benefit in the follow-up of pancreatic carcinoma. Anticancer Research 19(4a): 2437-2442
De Winter, F.; Gemmel, F.; Van De Wiele, C.; Poffijn, B.; Uyttendaele, D.; Dierckx, R. 2003: 18-Fluorine fluorodeoxyglucose positron emission tomography for the diagnosis of infection in the postoperative spine. Spine 28(12): 1314-1319
Yen, R.-F.; Hung, R.-L.; Pan, M.-H.; Wang, Y.-H.; Huang, K.-M.; Lui, L.T.; Kao, C.-H. 2003: 18-fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging. Cancer 98(2): 283-287
Laking, G.; Price, P. 2001: 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer. Thorax 56(Suppl 2): Ii38-Ii44
Witzenbichler, B.; Schulze-Bahr, E.; Haverkamp, W.; Breithardt, G.; Sticherling, C.; Behrens, S.; Schultheiss, H.P. 2003: 18-Jaehrige Patientin mit antiepileptischer Therapie und Kammerflimmern: Kasuistik eines hochmalignen LQT2-Syndroms. Zeitschrift fuer Kardiologie 92(9): 747-753
Glick, S.D.; Maisonneuve, I.M.; Dickinson, H.A. 2000: 18-MC reduces methamphetamine and nicotine self-administration in rats. Neuroreport 11(9): 2013-2015
Dabis, F.; Elenga, N.; Meda, N.; Leroy, V.; Viho, I.; Manigart, O.; Dequae-Merchadou, L.; Msellati, P.; Sombie, I. 2001: 18-Month mortality and perinatal exposure to zidovudine in West Africa. Aids 15(6): 771-779
Böhmer, C.; Kirschner, U.; Wehner, F. 2001: 18-beta-Glycyrrhetinic acid (BGA) as an electrical uncoupler for intracellular recordings in confluent monolayer cultures. Pflugers Archiv: European Journal of Physiology 442(5): 688-692
Ivanov, I., V.; Groza, N., V.; Romanov, S., G.; Kuhn, H.; Myagkova, G., I. 2000: 18-iodooctadeca-(8Z,11Z)-dienoic acid as useful intermediate for the synthesis of special lipoxygenase substrates bearing bulky substituents at the omega-position. Tetrahedron 56(4): 553-556
Aho, S.; Uitto, J. 1999: 180-kD bullous pemphigoid antigen/type XVII collagen: Tissue-specific expression and molecular interactions with keratin 18. Journal of Cellular Biochemistry 72(3): 356-367
Robin, P.; Blondel-Megrelis, M. 2001: 1800 et 1840, physiologie vegetale et chimie agricole. 1. Saussure, une publication a ressusciter. Comptes Rendus de l'Academie d'Agriculture de France 87(4): 31-59
Han, S.H.; Zonneberg, B.A.; de Klerk, J.M.; Quirijnen, J.M.; van het Schip, A.D.; van Dijk, A.; Blijham, G.H.; van Rijk, P.P. 1999: 186Re-etidronate in breast cancer patients with metastatic bone pain. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 40(4): 639-642
Das, T.; Banerjee, S.; Samuel, G.; Sarma, H.D.; Ramamoorthy, N.; Pillai, M.R. 2000: 188Re-ethylene dicysteine: a novel agent for possible use in endovascular radiation therapy. Nuclear Medicine Communications 21(10): 939-945
Lee, E.B.; Shin, K.C.; Lee, Y.J.; Lee, Y.J.; Cheon, G.J.; Jeong, J.M.; Son, M.W.; Song, Y.W. 2003: 188Re-tin-colloid as a new therapeutic agent for rheumatoid arthritis. Nuclear Medicine Communications 24(6): 689-696
Inoue, T.; Shibasaki, T.; Oriuchi, N.; Aoyagi, K.; Tomiyoshi, K.; Amano, S.; Mikuni, M.; Ida, I.; Aoki, J.; Endo, K. 1999: 18F alpha-methyl tyrosine PET studies in patients with brain tumors. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 40(3): 399-405
Yasuda, S.; Fujii, H.; Nakahara, T.; Nishiumi, N.; Takahashi, W.; Ide, M.; Shohtsu, A. 2001: 18F-FDG PET detection of colonic adenomas. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 42(7): 989-992
Szakáll, S.; Esik, O.; Bajzik, Gábor.; Repa, I.; Dabasi, G.; Sinkovics, Ián.; Agoston, Péter.; Trón, L. 2002: 18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 43(1): 66-71
Kostakoglu, L.; Goldsmith, S.J. 2003: 18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 44(2): 224-239
Ioannidis, J.P.A.; Lau, J. 2003: 18F-FDG PET for the diagnosis and grading of soft-tissue sarcoma: a meta-analysis. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 44(5): 717-724
Tashiro, M.; Fujimoto, T.; Itoh, M.; Kubota, K.; Fujiwara, T.; Miyake, M.; Watanuki, S.; Horikawa, E.; Sasaki, H.; Ido, T. 1999: 18F-FDG PET imaging of muscle activity in runners. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 40(1): 70-76
Yun, M.; Kim, W.; Alnafisi, N.; Lacorte, L.; Jang, S.; Alavi, A. 2001: 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 42(12): 1795-1799
Kim, Y.Kyeong.; Lee, D.Soo.; Lee, S.Kun.; Chung, C.Kee.; Chung, J-Key.; Lee, M.Chul. 2002: (18)F-FDG PET in localization of frontal lobe epilepsy: comparison of visual and SPM analysis. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 43(9): 1167-1174
Hicks, R.J.; Kalff, V.; MacManus, M.P.; Ware, R.E.; Hogg, A.; McKenzie, A.F.; Matthews, J.P.; Ball, D.L. 2001: (18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 42(11): 1596-1604
Drzezga, A.; Arnold, S.; Minoshima, S.; Noachtar, S.; Szecsi, J.; Winkler, P.; Römer, W.; Tatsch, K.; Weber, W.; Bartenstein, P. 1999: 18F-FDG PET studies in patients with extratemporal and temporal epilepsy: evaluation of an observer-independent analysis. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 40(5): 737-746
Rini, J.N.; Leonidas, J.C.; Tomas, M.B.; Palestro, C.J. 2003: 18F-FDG PET versus CT for evaluating the spleen during initial staging of lymphoma. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 44(7): 1072-1074
Demura, Y.; Tsuchida, T.; Ishizaki, T.; Mizuno, S.; Totani, Y.; Ameshima, S.; Miyamori, I.; Sasaki, M.; Yonekura, Y. 2003: 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 44(4): 540-548
Forstrom, L.A.; Mullan, B.P.; Hung, J.C.; Lowe, V.J.; Thorson, L.M. 2000: 18F-FDG labelling of human leukocytes. Nuclear Medicine Communications 21(7): 691-694
Higashi, K.; Ueda, Y.; Arisaka, Y.; Sakuma, T.; Nambu, Y.; Oguchi, M.; Seki, H.; Taki, S.; Tonami, H.; Yamamoto, I. 2002: 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 43(1): 39-45
Lassen, U.; Daugaard, G.; Eigtved, A.; Damgaard, K.; Friberg, L. 1999: 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT). European Journal of Cancer 35(7): 1076-1082
Schirmer, M.; Calamia, K.T.; Wenger, M.; Klauser, A.; Salvarani, C.; Moncayo, R. 2003: 18F-Fluorodeoxyglucose-positron emission tomography: A new explorative perspective. Experimental Gerontology 38(4): 463-470
Ceravolo, R.; Piccini, P.; Bailey, D.L.; Jorga, K.M.; Bryson, H.; Brooks, D.J. 2002: 18F-dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson's disease. Synapse 43(3): 201-207
Johnström, P.; Harris, N.G.; Fryer, T.D.; Barret, O.; Clark, J.C.; Pickard, J.D.; Davenport, A.P. 2002: (18)F-Endothelin-1, a positron emission tomography (PET) radioligand for the endothelin receptor system: radiosynthesis and in vivo imaging using microPET. Clinical Science 103(Suppl): 4s-8s
Chin, B.B.; Wahl, R.L. 2003: 18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies. Gut 52(Suppl 4): Iv23-Iv29
Sanchez, D.; Zudaire, J.J.; Fernandez, J.M.; Lopez, J.; Arocena, J.; Sanz, G.; Gimenez, M.; Rosell, D.; Robles, J.E.; Berian, J.M. 2002: 18F-fluoro-2-deoxyglucose-positron emission tomography in the evaluation of nonseminomatous germ cell tumours at relapse. BJU International 89(9): 912-916
Hoffmann, M.; Vogelsang, H.; Kletter, K.; Zettinig, G.; Chott, A.; Raderer, M. 2003: 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma. Gut 52(3): 347-351
Ullerich, H.; Franzius, C.H.; Domagk, D.; Seidel, M.; Sciuk, J.; Schober; Domschke, W. 2001: 18F-fluorodeoxyglucose PET in a patient with primary small bowel lymphoma: The only sensitive method of imaging. American Journal of Gastroenterology 96(8): 2497-2499
Stokkel, M.P.; Moons, K.G.; ten Broek, F.W.; van Rijk, P.P.; Hordijk, G.J. 1999: 18F-fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer. Cancer 86(11): 2370-2377
Hoffmann, M.; Kletter, K.; Becherer, A.; Jäger, U.; Chott, A.; Raderer, M. 2003: 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma. Oncology 64(4): 336-340
Fiorella, D.J.; Provenzale, J.M.; Coleman, R.E.; Crain, B.J.; Al-Sugair, A.A. 2001: (18)F-fluorodeoxyglucose positron emission tomography and MR imaging findings in Rasmussen encephalitis. Ajnr. American Journal of Neuroradiology 22(7): 1291-1299
Skehan, S.J.; Issenman, R.; Mernagh, J.; Nahmias, C.; Jacobson, K. 1999: 18F-fluorodeoxyglucose positron tomography in diagnosis of paediatric inflammatory bowel disease. Lancet 354(9181): 836-837
Hu, X.S.; Okamura, N.; Arai, H.; Higuchi, M.; Matsui, T.; Tashiro, M.; Shinkawa, M.; Itoh, M.; Ido, T.; Sasaki, H. 2000: 18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies. Neurology 55(10): 1575-1577
Tolvanen, T.; Lehtiö, K.; Kulmala, J.; Oikonen, V.; Eskola, O.; Bergman, Jörgen.; Minn, H. 2002: 18F-Fluoroerythronitroimidazole radiation dosimetry in cancer studies. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 43(12): 1674-1680
Goodman, M.M.; Kilts, C.D.; Keil, R.; Shi, B.; Martarello, L.; Xing, D.; Votaw, J.; Ely, T.D.; Lambert, P.; Owens, M.J.; Camp, V.M.; Malveaux, E.; Hoffman, J.M. 2000: 18F-labeled FECNT: A selective radioligand for PET imaging of brain dopamine transporters. Nuclear Medicine and Biology 27(1): 1-12
Seimbille, Y.; Rousseau, J.; Bénard, Fçois.; Morin, C.; Ali, H.; Avvakumov, G.; Hammond, G.L.; van Lier, J.E. 2002: 18F-labeled difluoroestradiols: Preparation and preclinical evaluation as estrogen receptor-binding radiopharmaceuticals. Steroids 67(9): 765-775
Zervos, E.E.; Desai, D.C.; DePalatis, L.R.; Soble, D.; Martin, E.W. 2001: 18F-labeled fluorodeoxyglucose positron emission tomography-guided surgery for recurrent colorectal cancer: a feasibility study. Journal of Surgical Research 97(1): 9-13
Varagnolo, L.; Stokkel, M.P.; Mazzi, U.; Pauwels, E.K. 2000: 18F-labeled radiopharmaceuticals for PET in oncology, excluding FDG. Nuclear Medicine and Biology 27(2): 103-112
Van Den Bossche, B.; Lambert, B.; De Winter, F.; Kolindou, A.; Dierckx, R.A.; Noens, L.; Van De Wiele, C. 2002: 18FDG PET versus high-dose 67Ga scintigraphy for restaging and treatment follow-up of lymphoma patients. Nuclear Medicine Communications 23(11): 1079-1083
Thorley, P.J.; Beacock, D.J.; Trickett, C.A.; Sivananthan, U.M. 2000: 18FDG SPECT to assess myocardial viability: initial experience at a hospital remote from a cyclotron. Nuclear Medicine Communications 21(8): 715-718
Al-Essa, M.; Bakheet, S.; Patay, Z.; Al-Shamsan, L.; Al-Sonbul, A.; Al-Watban, J.; Powe, J.; Ozand, P.T. 1999: 18Fluoro-2-deoxyglucose (18FDG) PET scan of the brain in propionic acidemia: Clinical and MRI correlations. Brain and Development 21(5): 312-317
Al-Essa, M.; Bakheet, S.; Al-Shamsan, L.; Patay, Z.; Powe, J.; Ozand, P.T. 1999: 18Fluoro-2-deoxyglucose (18FDG) PET scan of the brain in type IV 3-methylglutaconic aciduria: Clinical and MRI correlations. Brain and Development 21(1): 24-29
Eubank, W.B.; Mankoff, D.A.; Takasugi, J.; Vesselle, H.; Eary, J.F.; Shanley, T.J.; Gralow, J.R.; Charlop, A.; Ellis, G.K.; Lindsley, K.L.; Austin-Seymour, M.M.; Funkhouser, C.P.; Livingston, R.B. 2001: 18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 19(15): 3516-3523
Stewart, I.I.; Thomson, T.; Figeys, D. 2001: 18O labeling: a tool for proteomics. Rapid Communications in Mass Spectrometry: Rcm 15(24): 2456-2465
Porra, R.J.; Scheer, H. 2000: (18)O and mass spectrometry in chlorophyll research: Derivation and loss of oxygen atoms at the periphery of the chlorophyll macrocycle during biosynthesis, degradation and adaptation. Photosynthesis Research 66(3): 159-175
Burda, K.; Bader, K.P.; Schmid, G.H. 2003: 18O isotope effect in the photosynthetic water splitting process. Biochimica et Biophysica Acta 1557(1-3): 77-82
Izumikawa, M.; Murata, M.; Tachibana, K.; Fujita, T.; Naoki, H. 2000: 18O-labelling pattern of okadaic acid from H218O in dinoflagellate Prorocentrum lima elucidated by tandem mass spectrometry. European Journal of Biochemistry 267(16): 5179-5183
Spiro, B.; Roberts, M.; Gage, J.; Chenery, S. 2000: (18)O/(16)O and (13)C/(12)C in an ahermatypic deep-water coral Lophelia pertusa from the North Atlantic: a case of disequilibrium isotope fractionation. Rapid Communications in Mass Spectrometry: Rcm 14(15): 1332-1336
Dick, M.W.; Vick, M.C.; Gibbings, J.G.; Hedderson, T.A.; Lopez Lastra, C.C. 1999: 18S rDNA for species of Leptolegnia and other Peronosporomycetes: Justification for the subclass taxa Saprolegniomycetidae and Peronosporomycetidae and division of the Saprolegniaceae sensu lato into the Leptolegniaceae and Saprolegniaceae. Mycological Research 103(9): 1119-1125
Berger, S.; Fettweiss, U.; Gleissberg, S.; Liddle, L., B.; Richter, U.; Sawitzky, H.; Zuccarello, G., C. 2003: 18S rDNA phylogeny and evolution of cap development in Polyphysaceae (formerly Acetabulariaceae; Dasycladales, Chlorophyta). Phycologia 42(5): 506-561
Ouvrard, D.; Campbell, B.C.; Bourgoin, T.; Chan, K.L. 2000: 18S rRNA secondary structure and phylogenetic position of Peloridiidae (Insecta, hemiptera). Molecular Phylogenetics and Evolution 16(3): 403-417
Xia, X.; Xie, Z.; Kjer, K.M. 2003: 18S ribosomal RNA and tetrapod phylogeny. Systematic Biology 52(3): 283-295
D.N., A.M.; Martinez Rossi, N.M. 2001: 18S-rDNA sequencing, enzyme patterns and morphological characterization of Trichophyton isolates. Brazilian Journal of Microbiology 32(3): 179-186
Lipschutz, W.; Cadranel, S.; Lipschutz, B.; Martin, L.; Clees, N.; Martin, J.J.; Wauters, J.G.; Coucke, P.; Willems, P. 1999: 18q-syndrome with coeliac disease. European Journal of Pediatrics 158(6): 528
Bretzel, R.G. 1998: 18th Workshop of the Study Group on Artificial Insulin Delivery Systems, Pancreas and Islet Transplantation of the European Association for the Study of Diabetes (Igls, Austria; January 24-26, 1999). Acta Diabetologica 35(4): 232-247
Milla, P.; Viola, F.; Ceruti, M.; Rocco, F.; Cattel, L.; Balliano, G. 1999: 19-Azasqualene-2,3-epoxide and its N-oxide: metabolic fate and inhibitory effect on sterol biosynthesis in Saccharomyces cerevisiae. Lipids 34(7): 681-688
Molnár, Ián.; Kute, T.; Willingham, M.C.; Powell, B.L.; Dodge, W.H.; Schwartz, G.G. 2003: 19-nor-1alpha,25-dihydroxyvitamin D(2) (paricalcitol): effects on clonal proliferation, differentiation, and apoptosis in human leukemic cell lines. Journal of Cancer Research and Clinical Oncology 129(1): 35-42
Takeda, Y.; Yoneda, T.; Demura, M.; Furukawa, K.; Usukura, M.; Mabuchi, H. 2002: 19-Noraldosterone in pregnancy-induced hypertension. Steroids 67(7): 605-610
Numazawa, M.; Yamada, K.; Kidokoro, K. 1999: 19-oxygenated derivatives of androst-4-ene-6,17-dione and androst-5-ene-4,17-dione as catalytic probes for the active site of aromatase. Biological and Pharmaceutical Bulletin 22(10): 1134-1136
Numazawa, M.; Yamada, K.; Nagaoka, M. 2001: 19-Oxygenation of C19-steroids with an A, B-ring enone structure, competitive inhibitors of estrogen biosynthesis, with human placental aromatase. Biological and Pharmaceutical Bulletin 24(4): 332-335
Numazawa, M.; Nagaoka, M.; Morio, M.; Kamiyama, T. 1999: 19-oxygenations of 3-deoxy androgens, potent competitive inhibitors of estrogen biosynthesis, with human placental aromatase. Journal of Steroid Biochemistry and Molecular Biology 71(5-6): 173-179
Lombardi, V.R.; Cacabelos, R. 1999: 19/20 kDa low molecular weight serum protein pattern: A novel potential biochemical prognostic marker for different types of dementia. Neuroscience Letters 260(1): 61-64
Fanning, T.G.; Slemons, R.D.; Reid, A.H.; Janczewski, T.A.; Dean, J.; Taubenberger, J.K. 2002: 1917 avian influenza virus sequences suggest that the 1918 pandemic virus did not acquire its hemagglutinin directly from birds. Journal of Virology 76(15): 7860-7862
Moga, M.M. 1998: 192 IgG-saporin abolishes p75 neurotrophin receptor immunoreactivity in rat SCN. Neuroreport 9(14): 3197-3200
Bailey, A.M.; Rudisill, M.L.; Hoof, E.J.; Loving, M.L. 2003: 192 IgG-saporin lesions to the nucleus basalis magnocellularis (nBM) disrupt acquisition of learning set formation. Brain Research 969(1-2): 147-159
Mulcahy, M.; McInerney, J.G.; Nikogosyan, D.N.; Görner, H. 2000: 193 nm photolysis of aromatic and aliphatic dipeptides in aqueous solution: dependence of decomposition quantum yield on the amino acid sequence. Biological Chemistry 381(12): 1259-1262
Pecking, A.P.; Mechelany-Corone, C.; Pichon, M.F. 2000: 1959-1999: Des marqueurs seriques au 18-FDG en oncologie. L'experience du centre Rene-Huguenin. Pathologie Biologie 48(9): 819-824
Wellens, H.J. 1998: 1967-1997: Thirty years of cardiac arrhythmias. European Heart Journal 19(7): 984-989
Donaldson, L.J.; Morris, J. 2001: 1969 revisited: reflections on Tomorrow's community physician. International Journal of Epidemiology 30(5): 1172-1178
Petitou, M.; Casu, B.; Lindahl, U. 2003: 1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding site. Biochimie 85(1-2): 83-89
Sun, X.; Mu, R.; Zhou, Y.; Dai, X.; Qiao, Y.; Zhang, S.; Huangfu, X.; Sun, J.; Li, L.; Lu, F. 2002: 1990-1992 mortality of stomach cancer in China. Zhonghua Zhong Liu Za Zhi 24(1): 4-8
Munroe, P.B.; Knight, J.; Caulfield, M.J. 2000: 1990-2000: progress in determining high blood pressure genes. Annals of the Academy of Medicine Singapore 29(3): 357-363
Aoshima, T. 1998: 1991 epidemiological survey of dermatophytosis at Otsu Red Cross Hospital. Acta Dermatologica 93(3): 297-301
Espeland, M.A.; Craven, T.E.; Miller, M.E.; D'Agostino, R. 1999: 1996 Remington lecture: Modeling multivariate longitudinal data that are incomplete. Annals of Epidemiology 9(3): 196-205
Amenábar, J.J.; García-López, F.; Robles, N.R.; Saracho, R.; Calero, M.; Gentil, M.A.; Aladren, M.J.; Martín-Martinez, E.; Bestard, J.; Marco, J.; Lorenzo, V.; Martín De Francisco, A.L.; Sierra, T.; Rodrigo, A.; Clèries, M.; Vela, E.; Otero, F.; Sánchez-Casajús, A.; Rodríguez-Gironés, M.; Solozábal, C.; Magaz, A.; García-Blasco, M.J.; Zurriaga, O.; Zamora, I.; Vallo, A. 1999: 1997 spanish nephrology association (Sociedad Española de nefrologia) report on dialysis and transplantation. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 14(12): 2841-2845
Ysart, G.; Miller, P.; Croasdale, M.; Crews, H.; Robb, P.; Baxter, M.; de L'Argy, C.; Harrison, N. 2000: 1997 UK Total Diet Study--dietary exposures to aluminium, arsenic, cadmium, chromium, copper, lead, mercury, nickel, selenium, tin and zinc. Food Additives and Contaminants 17(9): 775-786
Us-Public-Health-Service-And-Infectious-Diseases-Society-Of-America 1998: 1997 US Public Health Service (USPHS)/Infectious Diseases Society of America (IDSA) Report on the prevention of opportunistic infections in patients infected with human immunodeficiency virus. Pediatrics 102(4 Part 2): 1064-1085
Boutillier, J.A.; Bond, J.A.; Harbo, R.M. 1998: 1997 industry sponsored shrimp surveys and resulting management actions: Area 12, April and November 1997. Canadian Manuscript Report of Fisheries and Aquatic Sciences 1998(2458): I-VI, 1-94
Duzcan, F.; Kilic, I.; Zincir, M.; Cetin, G.O.an 2001: 1997-1999 yillari arasinda Pamukkale Universitesi Egitim Uygulama ve Arastirma Hastanesi'nde dogan bebeklerde konjenital malformasyon sikligi. Cocuk Sagligi ve Hastaliklari Dergisi 44(3): 240-246
O'Leary, M.P.; Gee, W.F.; Holtgrewe, H.L.; Blute, M.L.; Cooper, T.P.; Meyer, J.J.; Miles, B.J.; Naslund, M.J.; Nellans, R.E.; Thomas, R.; Painter, M.R.; Blizzard, R.; Fenninger, R.B. 1999: 1998 American Urological Association Gallup Survey: Changes in physician practice patterns, treatment of ureteral stones and impact of managed care. Journal of Urology 162(5): 1702-1704
Lee, J.S. 2000: 1998 Distinguished lecture: Biomechanics of the microcirculation, an integrative and therapeutic perspective. Annals of Biomedical Engineering 28(1): 1-13
Bauernfeind, R.J. 2000: 1998 Distribution of Brood IV Magicicada (Homoptera: Cicadidae) in Kansas. Journal of the Kansas Entomological Society 73(4): 238-241
Raehl, C.L.; Bond, C.A. 2000: 1998 National clinical pharmacy services study. Pharmacotherapy 20(4): 436-460
Bodmer, W.F. 1999: 1998 Runme Shaw Memorial Lecture: somatic evolution of cancer. Annals of the Academy of Medicine Singapore 28(3): 323-329
Romanishin, W.; Tegler, S.C.; Rettig, T.W.; Consolmagno, G.; Botthof, B. 2001: 1998 SM165: a large Kuiper belt object with an irregular shape. Proceedings of the National Academy of Sciences of the United States of America 98(21): 11863-11866
Gerhart, J. 1999: 1998 Warkany lecture: signaling pathways in development. Teratology 60(4): 226-239
Harrington, J.M.; Legge, T. 1999: 1998 and beyond--Legge's legacy to modern occupational health. Annals of Occupational Hygiene 43(1): 1-6
Prah, J.D. 1998: 1998 equivalence of sensory responses to single and mixed volatile organic compounds at equimolar concentrations. Environmental Health Perspectives 106(11): 739-744
Mercuri, A.-Maria; Barbieri, G.; Storci, M.-Chiara 1999: 1998 pollen calendar-2-hourly airborne pollen monitoring station-University of Modena and Reggio Emilia (Botanical Garden/Geophysical Observatory). Atti della Societa dei Naturalisti e Matematici di Modena 130: 5-44
Vilsan, D.; Vonica, I. 2002: 1998 results of monitoring Diabrotica virgifera virgifera LeConte in Romania. Acta Phytopathologica et Entomologica Hungarica 37(1-3): 175-182
Berger, H.K.; Baufeld, P.; Pajmon, A.; Reynauld, P.; Sivicek, P.; Ulvee, C.C.; Urek, G. 2002: 1998-1999 detection survey results of Diabrotica virgifera virgifera LeConte in non-infested European countries. Acta Phytopathologica et Entomologica Hungarica 37(1-3): 183-192
Dröscher, A.; Golgi, C. 1998: 1998: The centenary of the discovery of the Golgi apparatus. Glycoconjugate Journal 15(8): 733-736
O'Leary, M.P.; Gee, W.F.; Holtgrewe, H.L.; Blute, M.L.; Cooper, T.P.; Miles, B.J.; Nellans, R.E.; Thomas, R.; Painter, M.R.; Meyer, J.J.; Naslund, M.J.; Gormley, E.A.; Blizzard, R.; Fenninger, R.B. 2000: 1999 American Urological Association Gallup survey: Changes in physician practice patterns, treatment of incontinence and bladder cancer, and impact of managed care. Journal of Urology 164(4): 1311-1316
Taylor, E.W. 2001: 1999 E.B. Wilson lecture: the cell as molecular machine. Molecular Biology of the Cell 12(2): 251-254
Tall, A.R.; Jiang, X.c.; Luo, Y.; Silver, D. 2000: 1999 George Lyman Duff memorial lecture: lipid transfer proteins, HDL metabolism, and atherogenesis. Arteriosclerosis Thrombosis and Vascular Biology 20(5): 1185-1188
Usphs/Idsa-Prevention-Of-Opportunistic-Infections-Working-Group 1999: 1999 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus. Annals of Internal Medicine 131(11): 873-908
Ryan, T.J.; Antman, E.M.; Brooks, N.H.; Califf, R.M.; Hillis, L.D.; Hiratzka, L.F.; Rapaport, E.; Riegel, B.; Russell, R.O.; Smith, E.E.; Weaver, W.D.; Gibbons, R.J.; Alpert, J.S.; Eagle, K.A.; Gardner, T.J.; Garson, A.; Gregoratos, G.; Smith, S.C. 1999: 1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 100(9): 1016-1030
Persson, M.; Carlberg, B.; Mjörndal, T.; Asplund, K.; Bohlin, J.; Lindholm, L. 2002: 1999 WHO/ISH Guidelines applied to a 1999 MONICA sample from northern Sweden. Journal of Hypertension 20(1): 29-35
Kimmel, C.A. 2001: 1999 Warkany lecture: improving the science for predicting risks to children's health. Teratology 63(5): 202-209
Anonymous 1999: 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. Journal of Hypertension 17(2): 151-183
Lammert, S.A. 1999: 1999 directory of mass spectrometry manufactures and suppliers. Rapid Communications in Mass Spectrometry 13(10): 831-844
Atagi, D.Y.; Diewert, R.E.; Bratty, J.M.; Walthers, L.C.; Irvine, J.R. 1999: 1999. 1993 and 1994 coho spawning escapement and juvenile studies in Louis and Lemieux creeks (North Thompson River). Canadian Manuscript Report of Fisheries and Aquatic Sciences 1999(2474): i-vii;1-80
Sturhahn, J.C.; Nagtegaal, D.A.; Trenholme, M. 1999: 1999. Abundance, age, size, sex and coded-wire tag recoveries for chinook salmon escapements of Campbell and Quinsam rivers, 1997. Canadian Manuscript Report of Fisheries and Aquatic Sciences 1999(2477): i-vii;1-49
Ruprecht, R.M.; Hofmann-Lehmann, R.; Rasmussen, R.A.; Vlasak, J.; Xu, W. 2000: 1999: a time to re-evaluate AIDS vaccine strategies. Journal of Human Virology 3(2): 88-93
Berra, Alessandra; Di-Vona, Maria-Luisa; Floris, Barbara; Licoccia, Silvia 2000: 199Hg NMR: A tool for direct detection of the products from acetoxymercuration of alkynes. Applied Organometallic Chemistry 14(10): 565-569
Lee, H.W.; Sohn, J.H.; Yeh, B.I.; Choi, J.W.; Jung, S.; Kim, H.W. 2000: 19F NMR investigation of F(1)-ATPase of Escherichia coli using fluorotryptophan labeling. Journal of Biochemistry 127(6): 1053-1056
Omran, A.A.; Kitamura, K.; Takegami, S.; Kume, M.; Yoshida, M.; El-Sayed, A.Aziz.Y.; Mohamed, M.H.; Abdel-Mottaleb, M. 2002: 19F NMR spectrometric determination of the partition coefficients of some fluorinated psychotropic drugs between phosphatidylcholine bilayer vesicles and water. Journal of Pharmaceutical and Biomedical Analysis 30(4): 1087-1092
Salopek-Sondi, B.; Vaughan, M.D.; Skeels, M.C.; Honek, J.F.; Luck, L.A. 2003: (19)F NMR studies of the leucine-isoleucine-valine binding protein: evidence that a closed conformation exists in solution. Journal of Biomolecular Structure and Dynamics 21(2): 235-246
Cao, B.; Endsley, S.; Andersen, N.H. 2003: 19F NMR studies of tryptophan/serum albumin binding. Bioorganic and Medicinal Chemistry 11(1): 69-75, 2 January
Kwon, K.; Jiang, Y.L.; Song, F.; Stivers, J.T. 2002: 19F NMR studies of vaccinia type IB topoisomerase. Conformational dynamics of the bound DNA substrate. Journal of Biological Chemistry 277(1): 353-358
Skeels, M.C.; Sondi, B.S.; Luck, L.A. 1999: 19F NMR study of the binding of fluorinated diethylstibestrol to the human estrogen receptor. Protein and Peptide Letters 6(3): 149-154
Nöth, U.; Gröhn, P.; Jork, A.; Zimmermann, U.; Haase, A.; Lutz, J. 1999: 19F-MRI in vivo determination of the partial oxygen pressure in perfluorocarbon-loaded alginate capsules implanted into the peritoneal cavity and different tissues. Magnetic Resonance in Medicine 42(6): 1039-1047
Laukemper-Ostendorf, S.; Scholz, A.; Bürger, K.; Heussel, C.P.; Schmittner, M.; Weiler, N.; Markstaller, K.; Eberle, B.; Kauczor, H-Ulrich.; Quintel, M.; Thelen, M.; Schreiber, W.G. 2002: 19F-MRI of perflubron for measurement of oxygen partial pressure in porcine lungs during partial liquid ventilation. Magnetic Resonance in Medicine 47(1): 82-89
Schwarz, R.; Schuurmans, M.; Seelig, J.; Künnecke, B. 1999: 19F-MRI of perfluorononane as a novel contrast modality for gastrointestinal imaging. Magnetic Resonance in Medicine 41(1): 80-86
Lenz, E.M.; Lindon, J.C.; Nicholson, J.K.; Weeks, J.M.; Osborn, D. 2002: 19F-NMR and directly coupled 19F/1H-HPLC-NMR spectroscopic investigations of the metabolism of the model ecotoxin 3-trifluoromethylaniline in the earthworm species Eisenia veneta. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 32(6): 535-546
Isobe, M.; Fujii, T.; Kuse, M.; Miyamoto, K.; Koga, K. 2002: 19F-dehydrocoelenterazine as probe to investigate the active site of symplectin. Tetrahedron 58(11): 2117-2126, 11 March
Pirrung, M.C.; Park, K.; Tumey, L.Nathan. 2002: (19)F-encoded combinatorial libraries: discovery of selective metal binding and catalytic peptoids. Journal of Combinatorial Chemistry 4(4): 329-344
Riva, P.; Dalprá, L.; Gualandri, V.; Volontè, M.; Miozzo, M.; Malgara, R.; Conti, A.F.; Larizza, L. 2000: 19p deletion in recurring leiomyosarcoma lesions from the same patient. Cancer Genetics and Cytogenetics 119(2): 102-108
Moser, K.A.; Smol, J.P.; Macdonald, G.M.; Larsen, C.P.S. 2002: 19th century eutrophication of a remote boreal lake: A consequence of climate warming?. Journal of Paleolimnology 28(2): 269-281
Bayorh, M.A.; Eatman, D.; Walton, M.; Socci, R.R.; Thierry-Palmer, M.; Emmett, N. 2002: 1A-779 attenuates angiotensin-(1-7) depressor response in salt-induced hypertensive rats. Peptides 23(1): 57-64
Corletto, D.; Broggi, S.; Fiorino, C.; Mangili, P.; Calandrino, R.; Lev, A.; Gennari, D.; Rudello, F. 1999: 1D dynamic beam modulation: methods to counteract inertia effects. Physics in Medicine and Biology 44(11): N233-N241
Labeau, F. 2001: 1EOSS. Primera Encuesta Online sobre Sexualidad. Informe y resultados preliminares. Prensa Medica Argentina 88(10): 970-974
Brambilla, P.; Stanley, J.A.; Nicoletti, M.; Harenski, K.; Wells, K.F.; Mallinger, A.G.; Keshavan, M.S.; Soares, J.C. 2002: 1H MRS brain measures and acute lorazepam administration in healthy human subjects. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 26(4): 546-551
Heikkinen, S.; Kangasmäki, A.; Timonen, M.; Kankaanranta, L.; Häkkinen, A.M.; Lundbom, N.; Vähätalo, J.; Savolainen, S. 2003: 1H MRS of a boron neutron capture therapy 10B-carrier, L-p-boronophenylalanine-fructose complex, BPA-F: phantom studies at 1.5 and 3.0 T. Physics in Medicine and Biology 48(8): 1027-1039
Suhy, J.; Laxer, K.D.; Capizzano, A.A.; Vermathen, P.; Matson, G.B.; Barbaro, N.M.; Weiner, M.W. 2002: 1H MRSi predicts surgical outcome in MRI-negative temporal lobe epilepsy. Neurology 58(5): 821-823
Feng, J.; Li, X.; Pei, F.; Chen, X.; Li, S.; Nie, Y. 2002: 1H NMR analysis for metabolites in serum and urine from rats administrated chronically with La(NO3)3. Analytical Biochemistry 301(1): 1-7
Avasthi, K.; Rawat, D., S.; Maulik, P., R.; Sarkhel, S.; Broder, C., K.; Howard, J., A.K. 2001: 1H NMR and X-ray crystallographic analysis of 1,2-bis(4,6-diethylthio-1H-pyrazolo(3,4-d)pyrimidin-1-yl)ethane and its 'propylene linker'-analog: Molecular recognition versus crystal engineering. Tetrahedron Letters 42(40): 7115-7117
Lens, P.; Vergeldt, F.; Lettinga, G.; Van-As, H. 1999: 1H NMR characterisation of the diffusional properties of methanogenic granular sludge. Water Science and Technology 39(7): 187-194
Poznański, J.; Felczak, K.; Bretner, M.; Kulikowski, T.; Remin, M. 2001: 1H NMR conformational study of a variety of alpha-anomers of C5-substituted 2'-deoxyuridines: comparison to their antiherpetic beta counterparts. Biochemical and Biophysical Research Communications 283(5): 1142-1149
Poznański, J.; Felczak, K.; Kulikowski, T.; Remin, M. 2000: 1H NMR conformational study of antiherpetic C5-substituted 2'-deoxyuridines: insight into the nature of structure-activity relationships. Biochemical and Biophysical Research Communications 272(1): 64-74
Bhattacharya, P.K.; Cha, J.; Barton, J.K. 2002: 1H NMR determination of base-pair lifetimes in oligonucleotides containing single base mismatches. Nucleic Acids Research 30(21): 4740-4750
Samijlenko, S.P.; Alexeeva, I.V.; Palchykivs'ka, L.H.; Kondratyuk, I.V.; Stepanyugin, A.V.; Shalamay, A.S.; Hovorun, D.M. 1999: 1H NMR investigation on 6-azacytidine and its derivatives. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy 55(5): 1133-1141
Hansen, P.E.; Skibsted, U.; Nissen, J.; Rae, C.D.; Kuchel, P.W. 2001: 1H NMR of compounds with low water solubility in the presence of erythrocytes: Effects of emulsion phase separation. European Biophysics Journal: Ebj 30(1): 69-74
Battistuzzi, G.; Di Rocco, G.; Leonardi, A.; Sola, M. 2003: 1H NMR of native and azide-inhibited laccase from Rhus vernicifera. Journal of Inorganic Biochemistry 96(4): 503-506
Battistuzzi, G.; Loschi, L.; Sola, M. 1999: 1H NMR of oxidized blue copper proteins. Journal of Inorganic Biochemistry 75(2): 153-157
Williams, R.E.; Jacobsen, M.; Lock, E.A. 2003: 1H NMR pattern recognition and 31P NMR studies with d-Serine in rat urine and kidney, time- and dose-related metabolic effects. Chemical Research in Toxicology 16(10): 1207-1216
Vernooij, E.A.; Gentry, C.A.; Herron, J.N.; Crommelin, D.J.; Kettenes-van den Bosch, J.J. 1999: 1H NMR quantification of poly(ethylene glycol)-phosphatidylethanolamine in phospholipid mixtures. Pharmaceutical Research 16(10): 1658-1661
Katritzky, A.R.; Akhmedov, N.G.; Denisenko, S.N.; Denisko, O.V. 2002: 1H NMR spectroscopic characterization of solutions of Sepia melanin, Sepia melanin free acid and human hair melanin. Pigment Cell Research 15(2): 93-97
Bubacco, L.; Salgado, J.; Tepper, A.W.; Vijgenboom, E.; Canters, G.W. 1999: 1H NMR spectroscopy of the binuclear Cu(II) active site of Streptomyces antibioticus tyrosinase. FEBS Letters 442(2-3): 215-220
Silva Elipe, M.V.; Bednarek, M.A.; Gao, Y.D. 2001: 1H NMR structural analysis of human ghrelin and its six truncated analogs. Biopolymers 59(7): 489-501
Veselkov, D.A.; Bolotin, P.O.; Sigaev, V.O.; Djimant, L.N.; Davies, D.B.; Veselkov, A.N. 2001: 1H NMR structural and thermodynamical analysis of complexation of propidium iodide with deoxytetranucleotide 5'-d(TpGpCpA) in aqueous solution. Biopolimery i Kletka 17(5): 363-373
Sulc, F.; Fleischer, E.; Farmer, P.J.; Ma, D.; La Mar, G.N. 2003: 1H NMR structure of the heme pocket of HNO-myoglobin. Journal of Biological Inorganic Chemistry: Jbic: a Publication of the Society of Biological Inorganic Chemistry 8(3): 348-352
Liu, W.; Vu, H.M.; Kearns, D.R. 2002: 1H NMR studies of a 17-mer DNA duplex. Biochimica et Biophysica Acta 1574(1): 93-99, 20 February
Byrne, B.; Rothchild, R. 1999: 1H NMR studies of drugs with achiral and chiral lanthanide shift reagents: applications to the anticonvulsant pheneturide. Chirality 11(7): 529-535
Kindahl, L.S.ndstrom, C.N.rberg, T.K.nne, L. 2000: 1H NMR studies of hydroxy protons of Asn- and Ser-linked disaccharides in aqueous solution. Journal of carbohydrate chemistry 19(9): 1291-1303
Bekiroglu, S.; Kenne, L.; Sandström, C. 2003: 1H NMR studies of maltose, maltoheptaose, alpha-, beta-, and gamma-cyclodextrins, and complexes in aqueous solutions with hydroxy protons as structural probes. Journal of Organic Chemistry 68(5): 1671-1678
Sandström, K.; Wärmländer, S.; Leijon, M.; Gräslund, A. 2003: 1H NMR studies of selective interactions of norfloxacin with double-stranded DNA. Biochemical and Biophysical Research Communications 304(1): 55-59
Johansen, F.; Jacobsen, J.P. 1998: 1H NMR studies of the bis-intercalation of a homodimeric oxazole yellow dye in DNA oligonucleotides. Journal of Biomolecular Structure and Dynamics 16(2): 205-222
Kato, N.; Nakamura, M.; Uchiyama, T. 1999: 1H NMR studies of the reactions of copper(I) and copper(II) with D-penicillamine and glutathione. Journal of Inorganic Biochemistry 75(2): 117-121
Li, R.K.rr, W.; Toledo, R.; Carpenter, J. 2000: 1H NMR studies of water in chicken breast marinated with different phosphates. Journal of food science 65(4): 575-580
Ferrer, S.; Naughton, D.P.; Threadgill, M.D. 2003: 1H NMR studies on the reductively triggered release of heterocyclic and steroid drugs from 4,7-dioxoindole-3-methyl prodrugs. Tetrahedron 59(19): 3445-3454
Traoré, A.; Foucat, L.; Renou, J.P. 2000: 1H NMR studies: Dynamics of water in gelatin. European Biophysics Journal: Ebj 29(3): 159-164
Shen, X-Jie.; Wang, Z-Bin.; Jiang, Y-Ping.; Chen, H-Lan. 2003: 1H NMR study of the inclusion of Costa-type organocobalt(III) complexes in cyclodextrins. Spectrochimica Acta. Part A Molecular and Biomolecular Spectroscopy 59(4): 803-809
Ghi, P.Y.; Hill, D.J.T.; Whittaker, A.K. 2002: (1)H NMR study of the states of water in equilibrium poly(HEMA-co-THFMA) hydrogels. Biomacromolecules 3(5): 991-997
Kovalainen, J.T.; Christiaans, J.A.M.; Poso, A.; Vepsalainen, J.; Laatikainen, R.; Gynther, J. 1999: 1H NMR study on putative intramolecular hydrogen bonding for histamine H3-receptor agonists. Tetrahedron Letters 40(12): 2425-2428
Wintjens, R.; Wieruszeski, J.M.; Drobecq, H.; Rousselot-Pailley, P.; Buée, L.; Lippens, G.; Landrieu, I. 2001: 1H NMR study on the binding of Pin1 Trp-Trp domain with phosphothreonine peptides. Journal of Biological Chemistry 276(27): 25150-25156
Cooper, W.A.; Bartier, W.A.; Rideout, D.C.; Delikatny, E.J. 2001: 1H NMR visible lipids are induced by phosphonium salts and 5-fluorouracil in human breast cancer cells. Magnetic Resonance in Medicine 45(6): 1001-1010
Fujii, R.; Chen, C.H.; Mizoguchi, T.; Koyama, Y. 1998: 1H NMR, electronic-absorption and resonance-Raman spectra of isomeric okenone as compared with those of isomeric beta-carotene, canthaxanthin, beta-apo-8'-carotenal and spheroidence. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy 54(5): 727-743
Di Vito, M.; Lenti, L.; Knijn, A.; Iorio, E.; D'Agostino, F.; Molinari, A.; Calcabrini, A.; Stringaro, A.; Meschini, S.; Arancia, G.; Bozzi, A.; Strom, R.; Podo, F. 2001: 1H NMR-visible mobile lipid domains correlate with cytoplasmic lipid bodies in apoptotic T-lymphoblastoid cells. Biochimica et Biophysica Acta 1530(1): 47-66
Everts, S.; Davis, J.H. 2000: 1H and (13)C NMR of multilamellar dispersions of polyunsaturated (22:6) phospholipids. Biophysical Journal 79(2): 885-897
Silwood, C.J.L.; Lynch, E.; Claxson, A.W.D.; Grootveld, M.C. 2002: 1H and (13)C NMR spectroscopic analysis of human saliva. Journal of Dental Research 81(6): 422-427
Mucci, A.; Schenetti, L.; Volpi, N. 2000: 1H and 13C nuclear magnetic resonance identification and characterization of components of chondroitin sulfates of various origin. Carbohydrate Polymers 41(1): 37-45
Mulhern, T.D.; Bagley, C.J.; Gaunt, C.; Lopez, A.F.; Vadas, M.A.; D'Andrea, R.J.; Booker, G.W. 1999: 1H and 15N chemical shift assignments for domain 4 of the common beta-chain of the IL-3, IL-5 and GM-CSF receptors. Journal of Biomolecular NMR 14(3): 281-282
Jensen, P.H.; Thomsen, N.K.; Soroka, V.; Berezin, V.; Bock, E.; Poulsen, F.M. 1998: 1H and 15N resonance assignment of neural cell adhesion molecule module-2. Journal of Biomolecular NMR 12(4): 569-570
Craescu, C.T.; Prêcheur, B.; van Riel, A.; Sakamoto, H.; Cox, J.A.; Engelborghs, Y. 1998: 1H and 15N resonance assignment of the calcium-bound form of the Nereis diversicolor sarcoplasmic Ca(2+)-binding protein. Journal of Biomolecular NMR 12(4): 565-566
Vittadini, E.D.ckinson, L.; Chinachoti, P. 2001: 1H and 2H NMR mobility in cellulose. Carbohydrate polymers 46(1): 49-57
Hentschel, M.; Oellinger, J.; Siewert, C.; Wieder, H.; Hosten, N.; Wendt, O.; Lüth, T.; Boenick, U.; Felix, R. 1999: 1H and 31P NMR characterisation of a double breast coil for spectroscopic measurements and imaging. Biomedizinische Technik. Biomedical Engineering 44(10): 272-277
Kruiskamp, M.J.; Van Vliet, G.; Nicolay, K. 2000: 1H and (31)P magnetization transfer studies of hindleg muscle in wild-type and creatine kinase-deficient mice. Magnetic Resonance in Medicine 43(5): 657-664
Sijens, P.E.; Oudkerk, M.; de Leeuw, F.E.; de Groot, J.C.; Achten, E.; Heijboer, R.; Hofman, A.; Breteler, M.M. 1999: 1H chemical shift imaging of the human brain at age 60-90 years reveals metabolic differences between women and men. Magnetic Resonance in Medicine 42(1): 24-31
Li, B.S.; Payne, G.S.; Collins, D.J.; Leach, M.O. 2000: 1H decoupling for in vivo (19)F MRS studies using the time-share modulation method on a clinical 1.5 T NMR system. Magnetic Resonance in Medicine 44(1): 5-9
Seo, Y.; Ikoma, K.; Takamiya, H.; Kusaka, Y.; Tsoref, L.; Eliav, U.; Shinar, H.; Navon, G. 1999: 1H double-quantum-filtered MR imaging as a new tool for assessment of healing of the ruptured Achilles tendon. Magnetic Resonance in Medicine 42(5): 884-889
Igarashi, H.; Kwee, I.L.; Nakada, T.; Katayama, Y.; Terashi, A. 2001: 1H magnetic resonance spectroscopic imaging of permanent focal cerebral ischemia in rat: Longitudinal metabolic changes in ischemic core and rim. Brain Research 907(1-2): 208-221
Krupnik, E.; Brière, K.M.; Bird, R.P.; Littman, C.; Smith, I.C. 1999: 1H magnetic resonance spectroscopy evidence that aberrant crypt foci are preneoplastic lesions in the colon. Anticancer Research 19(3a): 1699-1703
Sudo, M.; Sato, K.; Chaidedgumjorn, A.; Toyoda, H.; Toida, T.; Imanari, T. 2001: (1)H nuclear magnetic resonance spectroscopic analysis for determination of glucuronic and iduronic acids in dermatan sulfate, heparin, and heparan sulfate. Analytical Biochemistry 297(1): 42-51
Zhou, C.C.; Swaney, S.M.; Shinabarger, D.L.; Stockman, B.J. 2002: 1H nuclear magnetic resonance study of oxazolidinone binding to bacterial ribosomes. Antimicrobial Agents and ChemoTherapy 46(3): 625-629
Rácz, P.; Hargitai, C.; Alföldy, B.; Bánki, P.; Tompa, K. 2000: 1H spin-spin relaxation in normal and cataractous human, normal fish and bird eye lenses. Experimental Eye Research 70(4): 529-536
Codina, A.; Gairi, M.; Tarragó, T.; Viguera, A.R.; Feliz, M.; Ludevid, D.; Giralt, E. 2002: 1H(N), 15N, 13CO, 13Calpha, 13Cbeta assignment and secondary structure of a 20 kDa alpha-L-fucosidase from pea using TROSY. Journal of Biomolecular NMR 22(3): 295-296
Mo, H.; Dai, Y.; Pochapsky, S.S.; Pochapsky, T.C. 1999: 1H, 13C and 15N NMR assignments for a carbon monoxide generating metalloenzyme from Klebsiella pneumoniae. Journal of Biomolecular NMR 14(3): 287-288
Sibille, N.; Covès, J.; Marion, D.; Brutscher, B.; Bersch, B. 2001: 1H, 13C and 15N assignment of the flavodoxin-like domain of the Escherichia coli sulfite reductase. Journal of Biomolecular NMR 21(1): 71-72
Yalloway, G.N.; Löhr, F.; Wienk, H.L.; Mayhew, S.G.; Hrovat, A.; Knauf, M.A.; Rüterjans, H. 2003: 1H, 13C and 15N assignment of the hydroquinone form of flavodoxin from Desulfovibrio vulgaris (Hildenborough) and comparison of the chemical shift differences with respect to the oxidized state. Journal of Biomolecular NMR 25(3): 257-258
Jensen, P.H.; Thomsen, N.K.; Soroka, V.; Berezin, V.; Bock, E.; Poulsen, F.M. 1999: 1H, 13C and 15N assignments of the neural cell adhesion molecule module-1. Journal of Biomolecular NMR 14(2): 185-186
Elshorst, B.; Jacobs, D.M.; Schwalbe, H.; Langer, T. 2003: 1H, 13C and 15N backbone resonance assignment of the integrin alpha2 I-domain. Journal of Biomolecular NMR 27(2): 191-192
Vogtherr, M.; Grimme, S.; Pescatore, B.; Schwalbe, H. 2003: 1H, 13C and 15N backbone resonance assignment of the VASP EVH1 domain. Journal of Biomolecular NMR 27(2): 189-190
Jacobs, D.M.; Messens, J.; Wechselberger, R.W.; Brosens, E.; Willem, R.; Wyns, L.; Martin, J.C. 2001: 1H, 13C and 15N backbone resonance assignment of the arsenate reductase from Staphylococcus aureus in its reduced state. Journal of Biomolecular NMR 20(1): 95-96
Jacobs, D.M.; Saxena, K.; Grimme, S.; Vogtherr, M.; Pescatore, B.; Langer, T.; Elshorst, B.; Fiebig, K.M. 2002: 1H, 13C and 15N backbone resonance assignment of the peptidyl-prolyl cis-trans isomerase Pin1. Journal of Biomolecular NMR 23(2): 163-164
Shimizu, M.; Hiroaki, H.; Kohda, D.; Hayato Morita, E.; Hotta, S.; Morikawa, K. 2003: 1H, 13C and 15N backbone resonance assignments of the N-terminal domain of Drosophila GCM protein. Journal of Biomolecular NMR 26(3): 277-278
Bottomley, M.J.; Sattler, M. 2003: 1H, 13C and 15N backbone resonance assignments of the SAND domains from glucocorticoid modulatory element binding proteins-1 and -2. Journal of Biomolecular NMR 25(3): 259-260
Betz, M.; Löhr, F.; Wienk, H.; Rüterjans, H. 2002: 1H, 13C and 15N chemical shift assignment of Bacillus agaradhaerens family 11 xylanase. Journal of Biomolecular NMR 23(4): 333-334
Birlirakis, N.; Briand, L.; Pernollet, J.C.; Guittet, E. 2001: 1H, 13C and 15N chemical shift assignment of the honeybee pheromone carrier protein ASP1. Journal of Biomolecular NMR 20(2): 183-184
Hemmi, H.; Kuno, A.; Ito, S.; Kaneko, S.; Hasegawa, T. 2003: 1H, 13C and 15N chemical shift assignment of xylan-binding domain from Streptomyces olivaceoviridis E-86 beta-xylanase. Journal of Biomolecular NMR 27(1): 91-92
Miron, S.; Munier-Lehmann, H.; Craescu, C.T. 2001: 1H, 13C and 15N resonance assignment and secondary structure of Mycobacterium tuberculosis adenylate kinase. Journal of Biomolecular NMR 19(1): 89-90
Tu, X.; Wu, J.; Xu, Y.; Shi, Y. 2001: 1H, 13C and 15N resonance assignments and secondary structure of ADR6 DNA-binding domain. Journal of Biomolecular NMR 21(2): 187-188
Wu, B.; Arumugam, S.; Huang, W.; Brew, K.; Van Doren, S.R. 1999: 1H, 13C and 15N resonance assignments and secondary structure of the N-terminal domain of human tissue inhibitor of metalloproteinases-1. Journal of Biomolecular NMR 14(3): 289-290
Lou, Y.-C.; Pan, Y.-R.; Ho, Y.-H.; Liao, Y.-D.; Chen, C. 2003: 1H, 13C and 15N resonance assignments and secondary structure of the cytotoxic RNase 3 from oocytes of bullfrog Rana catesbeiana. Journal of Biomolecular NMR 27(3): 289-290
Hsu, C.H.; Liao, Y.D.; Wu, S.H.; Chen, C. 2001: 1H, 13C and 15N resonance assignments and secondary structure of the cytotoxic protein RNase 4 from bullfrog Rana catesbeiana oocytes. Journal of Biomolecular NMR 20(1): 93-94
Feng, Y.; Likos, J.; Zhu, L.; Woodward, H.; McDonald, J.; Stevens, A.; Howard, S.; Welsch, D. 2000: 1H, 13C and 15N resonance assignments for a truncated and inhibited catalytic domain of matrix metalloproteinase-2. Journal of Biomolecular NMR 17(1): 85-86
Zheng, D.; Cort, J.R.; Chiang, Y.; Acton, T.; Kennedy, M.A.; Montelione, G.T. 2003: 1H, 13C and 15N resonance assignments for methionine sulfoxide reductase B from Bacillus subtilis. Journal of Biomolecular NMR 27(2): 183-184
Gryk, M.R.; Maciejewski, M.W.; Robertson, A.; Mullen, M.A.; Wilson, S.H.; Mullen, G.P. 2002: 1H, 13C and 15N resonance assignments for the perdeuterated 22 kD palm-thumb domain of DNA polymerase beta. Journal of Biomolecular NMR 22(2): 197-198
Shi, G.; Gao, J.; Yan, H. 1999: 1H, 13C and 15N resonance assignments of Escherichia coli 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase and its complex with MgAMPPCP. Journal of Biomolecular NMR 14(2): 189-190
Liu, Q.; Li, S.S.-C. 2002: 1H, 13C and 15N resonance assignments of Gads C-terminal SH3 domain in complex with an RXXK motif-containing peptide derived from SLP-76. Journal of Biomolecular NMR 24(2): 161-162
Manzur, K.; Farooq, A.; Zeng, L.; Zhou, M.-M. 2003: 1H, 13C and 15N resonance assignments of a viral SET domain histone lysine methyltransferase. Journal of Biomolecular NMR 26(3): 279-280
Ko, S.-g.; Shin, J.; Yu, E.Y.; Chung, I.K.; Tanaka, T.; Lee, W. 2003: 1H, 13C and 15N resonance assignments of rice telomere binding domain from Oryza sativa. Journal of Biomolecular NMR 27(1): 89-90
Volk, D.E.; Thiviyanathan, V.; House, P.G.; Lloyd, R.S.; Gorenstein, D.G. 1999: 1H, 13C and 15N resonance assignments of the C-terminal domain of MutY: an adenine glycosylase active on G:A mismatches. Journal of Biomolecular NMR 14(4): 385-386
Headey, S.J.; Yao, S.; Parker, N.J.; Kantharidis, P.; Bach, L.A.; Norton, R.S. 2003: 1H, 13C and 15N resonance assignments of the C-terminal domain of insulin-like growth factor binding protein-6 (IGFBP-6). Journal of Biomolecular NMR 25(3): 251-252
Weigelt, J.; Climent, I.; Dahlman-Wright, K.; Wikström, M. 2000: 1H, 13C and 15N resonance assignments of the DNA binding domain of the human forkhead transcription factor AFX. Journal of Biomolecular NMR 17(2): 181-182
Kozlov, G.; Cheng, J.; Lievre, C.; Banville, D.; Gehring, K.; Ekiel, I. 2002: 1H, 13C and 15N resonance assignments of the human phosphatase PRL-3. Journal of Biomolecular NMR 24(2): 169-170
Lee, G.-i.; Li, J.; Walker, J.C.; Van Doren, S.R. 2003: 1H, 13C and 15N resonance assignments of the kinase-interacting FHA domain of Arabidopsis thaliana kinase-associated protein phosphatase. Journal of Biomolecular NMR 25(3): 253-254
Kalinin, A.; Rak, A.; Shcherbakov, D.; Bayer, P. 2002: 1H, 13C and 15N resonance assignments of the ribosome-associated cold shock response protein Yfia of Escherichia coli. Journal of Biomolecular NMR 23(4): 335-336
Smith, S.P.; Béguin, P.; Alzari, P.M.; Gehring, K. 2002: 1H, 13C, 15N NMR sequence-specific resonance assignment of a Clostridium thermocellum type Ii cohesin module. Journal of Biomolecular NMR 23(1): 73-74
Rustandi, R.; Vallely, K.M.; Varlamova, O.; Klein, M.G.; Almo, S.C.; Bresnick, A.R.; Weber, D.J. 2001: 1H, 13C, 15N NMR sequence-specific resonance assignments for human apo-Mts1 (S100A4). Journal of Biomolecular NMR 19(4): 381-382
Buchko, G.W.; Ni, S.; Holbrook, S.R.; Kennedy, M.A. 2003: 1H, (13)C, and (15)N NMR assignments of the hypothetical Nudix protein DR0079 from the extremely radiation-resistant bacterium Deinococcus radiodurans. Journal of Biomolecular NMR 25(2): 169-170
Vanbelle, C.; Muhle-Goll, C.; Remy, M.H.; Masson, J.M.; Marion, D.; Brutscher, B. 2000: 1H, 13C, and 15N assignment of a bleomycin resistance protein in its native form and in a complex with Zn2+ ligated bleomycin. Journal of Biomolecular NMR 18(2): 177-178
Campos-Olivas, R.ón.; Louis, J.M.; Clérot, D.; Gronenborn, B.; Gronenborn, A.M. 2002: 1H, 13C, and 15N assignment of the N-terminal, catalytic domain of the replication initiation protein from the geminivirus TYLCV. Journal of Biomolecular NMR 24(1): 73-74
Edlich, C.; Muhle-Goll, C. 2003: 1H, 13C, and 15N backbone assignment of the first two Ig domains Z1Z2 of the giant muscle protein Titin. Journal of Biomolecular NMR 27(3): 283-284
Marlow, M.S.; Chim, N.; Brown, C.B.; Barnett, J.V.; Krezel, A.M. 2000: 1H, 13C, and 15N backbone assignments of the ligand binding domain of TGFbeta type Ii receptor. Journal of Biomolecular NMR 17(4): 349-350
Pan, B.; Fairbrother, W.J. 2002: 1H, 13C, and 15N resonance assignment of the vascular endothelial growth factor receptor-binding domain in complex with a receptor-blocking peptide. Journal of Biomolecular NMR 22(2): 189-190
Szymczyna, B.R.; Pineda-Lucena, A.; Mills, J.L.; Szyperski, T.; Arrowsmith, C.H. 2002: 1H, 13C, and 15N resonance assignments and secondary structure of the PWi domain from SRm160 using reduced dimensionality NMR. Journal of Biomolecular NMR 22(3): 299-300
Muranyi, A.; Evenäs, J.; Stenberg, Y.; Stenflo, J.; Drakenberg, T. 2000: 1H, 15N and (13)C assignments and secondary structure of the EGF-like module pair 3-4 from vitamin K-dependent protein S. FEBS Letters 475(2): 135-138
Deane, J.E.; Visvader, J.E.; Mackay, J.P.; Matthew, J.M. 2002: 1H, 15N and 13C assignments of FLIN4, an intramolecular LMO4:ldb1 complex. Journal of Biomolecular NMR 23(2): 165-166
Amor, J.C.; Seidel, R.D.; Tian, F.; Kahn, R.A.; Prestegar, J.H. 2002: 1H, 15N and 13C assignments of full length human ADP ribosylation factor 1 (ARF1) using triple resonance connectivities and dipolar couplings. Journal of Biomolecular NMR 23(3): 253-254
McIntosh, P.B.; Taylor, I.A.; Smerdon, S.J.; Frenkiel, T.A.; Lane, A.N. 1999: 1H, 15N and 13C assignments of the DNA binding domain of transcription factor Mbp1 from S. cerevisiae in both its free and the DNA bound forms, and 1H assignments of the free DNA. Journal of Biomolecular NMR 13(4): 397-398
Khandelwal, P.; Keliikuli, K.; Smit, C.L.; Saper, M.A.; Zuiderweg, E.R. 2001: 1H, 15N and 13C assignments of the N-terminal domain of Yersinia outer protein H in its apo form and in complex with a phosphotyrosine peptide. Journal of Biomolecular NMR 21(1): 69-70
Christodoulou, J.; Hu, H.; Chung, J.; Rance, M.; Harper, J.F.; Chazin, W.J. 2002: 1H, 15N and 13C assignments of the regulatory domains of calcium-dependent protein kinase (CDPK). Journal of Biomolecular NMR 23(3): 249-250
Liu, G.; Guibao, C.D.; Zheng, J. 2002: 1H, 15N and 13C assignments of the targeting (FAT) domain of focal adhesion kinase. Journal of Biomolecular NMR 23(1): 75-76
Wang, C.; Hunt, J.F.; Rance, M.; Palmer, A.G. 2002: 1H, 15N and 13C backbone assignment of MJ1267, an ATP-binding cassette. Journal of Biomolecular NMR 24(2): 167-168
Khan, F.; Stott, K.; Jackson, S. 2003: 1H, 15N and 13C backbone assignment of the green fluorescent protein (GFP). Journal of Biomolecular NMR 26(3): 281-282
Ducat, T.; Declerck, N.; Kochoyan, M.; Déméné, H.él.èn. 2002: 1H, 15N and 13C backbone resonance assignments of the 40 kDa LicT-CAT-PRD1 protein. Journal of Biomolecular NMR 23(4): 325-326
Pérez, J.M.; Kriek, J.; Dijk, J.; Möller, W.; Siegal, G.; Hård, K.; Kalverda, A.P.; Canters, G.W. 1998: 1H, 15N and 13C chemical shift assignment of the guanine nucleotide exchange domain of human elongation factor-one beta. Journal of Biomolecular NMR 12(3): 467-468
Auguin, D.; Barthe, P.; Augé-Sénégas, M.-T.ér.ès.; Hoh, F.ço.; Noguchi, M.; Roumestand, C. 2003: 1H, 15N and 13C chemical shift assignments of the Pleckstrin Homology domain of the Human Protein Kinase B (PKB/Akt). Journal of Biomolecular NMR 27(3): 287-288
Wulf, J.; Pascuzzi, P.E.; Martin, G.B.; Nicholson, L.K. 2002: 1H, 15N and 13C chemical shift assignments of the structured core of the pseudomonas effector protein AvrPto. Journal of Biomolecular NMR 23(3): 247-248
Hsu, C.H.; Chen, L.W.; Liao, Y.D.; Wu, S.H.; Chen, C. 2001: 1H, 15N and 13C resonance assignments and secondary structure determination of the RC-RNase 2 from oocytes of bullfrog Rana catesbeiana. Journal of Biomolecular NMR 19(1): 87-88
Su, N.Y.; Liao, Y.D.; Chang, C.F.; Wanga, I.; Chena, C. 2001: 1H, 15N and 13C resonance assignments and secondary structure of the liver ribonuclease from bullfrog Rana catesbeiana. Journal of Biomolecular NMR 20(2): 189-190
Wu, H.; Maciejewski, M.W.; Benashski, S.E.; Mullen, G.P.; King, S.M. 1999: 1H, 15N and 13C resonance assignments for the 22 kDa LC1 light chain from Chlamydomonas outer arm dynein. Journal of Biomolecular NMR 13(3): 309-310
Mer, G.; Edwards, A.M.; Chazin, W.J. 2000: 1H, 15N and 13C resonance assignments for the C-terminal protein interaction region of the 32 kDa subunit of human replication protein a. Journal of Biomolecular NMR 17(2): 179-180
Chuang, W.-J.; Yeh, I.-J.; Hsieh, Y.-H.; Liu, P.-P.; Chen, S.-W.; Jeng, W.-Y. 2002: 1H, 15N and 13C resonance assignments for the DNA-binding domain of myocyte nuclear factor (Foxk1). Journal of Biomolecular NMR 24(1): 75-76
Deniau, C.; Couprie, J.; Simenel, C.; Kumar, V.; Stojiljkovic, I.; Wandersman, C.; Delepierre, M.; Lecroisey, A. 2001: 1H, 15N and 13C resonance assignments for the gallium protoporphyrin IX-HasA(sm) hemophore complex. Journal of Biomolecular NMR 21(2): 189-190
Farooq, A.; Zeng, L.; Zhou, M.-M. 2003: 1H, 15N and 13C resonance assignments for the PTB domain of the signaling protein Shc. Journal of Biomolecular NMR 25(3): 255-256
Wu, H.; Maciejewski, M.W.; Benashski, S.E.; Mullen, G.P.; King, S.M. 2001: 1H, 15N and 13C resonance assignments for the Tctex1 dynein light chain from Chlamydomonas flagella. Journal of Biomolecular NMR 20(1): 89-90
Dhalluin, C.; Carlson, J.E.; Zeng, L.; He, C.; Aggarwal, A.K.; Zhou, M.M. 1999: 1H, 15N and 13C resonance assignments for the bromodomain of the histone acetyltransferase P/CAF. Journal of Biomolecular NMR 14(3): 291-292
Hamilton, K., S.; Ellison, M., J.; Shaw, G., S. 2000: 1H, 15N and 13C resonance assignments for the catalytic domain of the yeast E2, UBC1. Journal of Biomolecular NMR 16(4): 351-352
Rintala, A.C.; Schönekess, B.O.; Walsh, M.P.; Shaw, G.S. 2002: 1H, 15N and 13C resonance assignments of rabbit apo-S100A11. Journal of Biomolecular Nmr 22(2): 191-192
Pai, M.-T.; Huang, K.-C.; Tzeng, S.-R.; Cheng, J.-W. 2002: 1H, 15N and 13C resonance assignments of the SH2 domain of Bruton's tyrosine kinase. Journal of Biomolecular NMR 24(2): 163-164
Ishida, H.; Nakashima, K-ichi.; Kumaki, Y.; Nakata, M.; Hikichi, K.; Yazawa, M. 2002: 1H, 15N and 13C resonance assignments of yeast Saccharomyces cerevisiae calmodulin in the Ca2+-free state. Journal of Biomolecular Nmr 23(4): 323-324
Marintchev, A.; Maciejewski, M.W.; Mullen, G.P. 1999: 1H, 15N, and 13C resonance assignments for the N-terminal 20 kDa domain of the DNA single-strand break repair protein XRCC1. Journal of Biomolecular NMR 13(4): 393-394
Rastogi, V.K.; Diven, C.F.; Seabrook, G.M.; Genbauffe, F.S.; Bechard, R.T.; Fandl, J.P.; Peters, K.G. 2002: 1H, 15N, and 13C resonance assignments of low molecular weight human cytoplasmic protein tyrosine phosphatase-A (HCPTP-A). Journal of Biomolecular NMR 23(3): 251-252
Suzuki, E.; Kashiwagi, A.; Hidaka, H.; Maegawa, H.; Nishio, Y.; Kojima, H.; Haneda, M.; Yasuda, H.; Morikawa, S.; Inubushi, T.; Kikkawa, R. 2000: 1H- and 31P-magnetic resonance spectroscopy and imaging as a new diagnostic tool to evaluate neuropathic foot ulcers in Type Ii diabetic patients. Diabetologia 43(2): 165-172
Péloponèse, J.M.; Grégoire, C.; Opi, S.; Esquieu, D.; Sturgis, J.; Lebrun, E.; Meurs, E.; Collette, Y.; Olive, D.; Aubertin, A.M.; Witvrow, M.; Pannecouque, C.; De Clercq, E.; Bailly, C.; Lebreton, J.; Loret, E.P. 2000: 1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein. Comptes Rendus de l'Academie des Sciences. Serie Iii Sciences de la Vie 323(10): 883-894
Orekhov, V.-Yu; Korzhnev, D., M.; Diercks, T.; Kessler, H.; Arseniev, A., S. 1999: 1H-15N NMR dynamic study of an isolated alpha-helical peptide (1-36)-bacteriorhodopsin reveals the equilibrium helix-coil transitions. Journal of Biomolecular NMR 14(4): 345-356
Yamasue, H.; Fukui, T.; Fukuda, R.; Yamada, H.; Yamasaki, S.; Kuroki, N.; Abe, O.; Kasai, K.; Tsujii, K.; Iwanami, A.; Aoki, S.; Ohtomo, K.; Kato, N.; Kato, T. 2002: 1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia. Neuroreport 13(16): 2133-2137
Catani, M.; Cherubini, A.; Howard, R.; Tarducci, R.; Pelliccioli, G.P.; Piccirilli, M.; Gobbi, G.; Senin, U.; Mecocci, P. 2001: (1)H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging. Neuroreport 12(11): 2315-2317
Mañeru, C.; Junqué, C.; Bargalló, N.; Olondo, M.; Botet, F.; Tallada, M.; Guardia, J.; Mercader, J.M. 2001: (1)H-MR spectroscopy is sensitive to subtle effects of perinatal asphyxia. Neurology 57(6): 1115-1118
Rutkowski, T.; Tarnawski, R.; Sokol, M.; Maciejewski, B. 2003: 1H-MR spectroscopy of normal brain tissue before and after postoperative radiotherapy because of primary brain tumors. International Journal of Radiation Oncology Biology Physics 56(5): 1381-1389
Pioro, E.P.; Majors, A.W.; Mitsumoto, H.; Nelson, D.R.; Ng, T.C. 1999: 1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla. Neurology 53(1): 71-79
Tarnawski, R.; Sokol, M.; Pieniazek, P.; Maciejewski, B.; Walecki, J.; Miszczyk, L.; Krupska, T. 2002: 1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas. International Journal of Radiation Oncology Biology Physics 52(5): 1271-1276
Rosi, A.; Luciani, A.M.; Matarrese, P.; Arancia, G.; Viti, V.; Guidoni, L. 1999: 1H-MRS lipid signal modulation and morphological and ultrastructural changes related to tumor cell proliferation. Magnetic Resonance in Medicine 42(2): 248-257
Nakagawa, Y.; Hattori, M.; Harada, K.; Bando, M.; Okano, G. 2003: 1H-MRS study on gender differences in intramuscular triglycerides in human skeletal muscle and their relation to body fat and endurance capacity. Tairyoku Kagaku 52(2): 149-158
Veselkov, D.A.; Sigaev, V.A.; Vysotsky, S.A.; Djimant, L.N.; Davies, D.B.; Veselkov, A.N. 2000: 1H-NMR analysis of hetero-association of caffeine with phenanthridinium dye propidium iodide in aqueous solution. Biopolimery i Kletka 16(3): 195-204
Veselkov, A.N.; Vysotsky, S.A.; Evstigneev, M.P.; Veselkov, D.A.; Djimant, L.N.; Bolotin, P.A.; Davies, D.B. 2002: 1H-NMR analysis of the interaction of antibiotic mitoxantrone with DNA in the presence of caffeine in aqueous solution. Biopolimery i Kletka 18(4): 287-296
Tugnoli, V.; Bottura, G.; Fini, G.; Reggiani, A.; Tinti, A.; Trinchero, A.; Tosi, M.R. 2003: 1H-NMR and 13C-NMR lipid profiles of human renal tissues. Biopolymers 72(2): 86-95
Nakamura, K.; Jung, Y.M.; Era, S.; Sogami, M.; Ozaki, Y.; Takasaki, A. 2000: 1H-NMR and Raman studies on perforating trauma-induced cataract formation in a mouse lens. Biochimica et Biophysica Acta 1474(1): 23-30
Kuroda, Y.; Maeda, Y.; Miyamoto, K.; Tanaka, K.; Kanaori, K.; Otaka, A.; Fujii, N.; Nakagawa, T. 1999: 1H-NMR and circular dichroism spectroscopic studies on changes in secondary structures of the sodium channel inactivation gate peptides as caused by the pentapeptide KIFMK. Biophysical Journal 77(3): 1363-1373
Faucci, M.T.; Melani, F.; Mura, P. 2000: 1H-NMR and molecular modelling techniques for the investigation of the inclusion complex of econazole with alpha-cyclodextrin in the presence of malic acid. Journal of Pharmaceutical and Biomedical Analysis 23(1): 25-31
Aboutabl, E.A.; Ei-Azzouny, A.A.; Afifi, M.S. 2002: 1H-NMR assay of papaverine hydrochloride and formulations. Phytochemical Analysis: Pca 13(6): 301-304
Nakanishi, I.; Fujikawa, A.; Imai, K.; Sato, A. 2000: 1H-NMR determination of the solution structure and absolute configuration of FR134043, a novel inhibitor of human leukocyte elastase. Journal of Peptide Research: Official Journal of the American Peptide Society 55(2): 120-128
Yamamoto, Y.; Nakashima, T.; Kawano, E.; Chûjô, R. 1998: 1H-NMR investigation of the influence of the heme orientation on functional properties of myoglobin. Biochimica et Biophysica Acta 1388(2): 349-362
Noula, C.; Bonzom, P.; Brown, A.; Gibbons, W.A.; Martin, J.; Nicolaou, A. 2000: 1H-NMR lipid profiles of human blood platelets; links with coronary artery disease. Biochimica et Biophysica Acta 1487(1): 15-23
Arnold, M.Reinhard.; Kremer, W.; Lüdemann, H.Dietrich.; Kalbitzer, H.Robert. 2002: 1H-NMR parameters of common amino acid residues measured in aqueous solutions of the linear tetrapeptides Gly-Gly-X-Ala at pressures between 0.1 and 200 MPa. Biophysical Chemistry 96(2-3): 129-140
Ono, H.; Yamada, H.; Matsuda, S.; Okajima, K.; Kawamoto, T.; IIjima, H. 1998: 1H-NMR relaxation of water molecules in the aqueous microcrystalline cellulose suspension systems and their viscosity. Cellulose 5(4): 231-247
't Hart, B.A.; Vogels, J.T.W.E.; Spijksma, G.; Brok, H.P.M.; Polman, C.; Van Der Greef, J. 2003: 1H-NMR spectroscopy combined with pattern recognition analysis reveals characteristic chemical patterns in urines of MS patients and non-human primates with MS-like disease. Journal of the Neurological Sciences 212(1-2): 21-30
Wevers, R.A.; Engelke, U.F.; Moolenaar, S.H.; Bräutigam, C.; de Jong, J.G.; Duran, R.; de Abreu, R.A.; van Gennip, A.H. 1999: 1H-NMR spectroscopy of body fluids: inborn errors of purine and pyrimidine metabolism. Clinical Chemistry 45(4): 539-548
Van Cappellen Van Walsum, A-Marie.; Jongsma, H.W.; Wevers, R.A.; Nijhuis, J.G.; Crevels, J.; Engelke, U.F.H.; De Abreu, R.A.; Moolenaar, S.H.; Oeseburg, B.; Nijland, R. 2002: 1H-NMR spectroscopy of cerebrospinal fluid of fetal sheep during hypoxia-induced acidemia and recovery. Pediatric Research 52(1): 56-63
Wilce, J.A.; Salvatore, D.; Wade, J.D.; Craik, D.J. 1999: 1H-NMR structural studies of a cystine-linked peptide containing residues 71-93 of transthyretin and effects of a Ser84 substitution implicated in familial amyloidotic polyneuropathy. European Journal of Biochemistry 262(2): 586-594
Lee, H.Mee.; Kim, J-Ki. 2002: H-NMR studies of duplex DNA decamer containing a uracil cyclobutane dimer: implications regarding the high UV mutagenecity of CC photolesions. Photochemistry and Photobiology 76(4): 417-422
Yamada, T. 2001: 1H-NMR studies of the intracellular water of skeletal muscle fibers under various physiological conditions. Cellular and Molecular Biology 47(5): 925-933
Davis, T.A.; Llanes, F.; Volesky, B.; Diaz-Pulido, G.; McCook, L.; Mucci, A. 2003: 1H-NMR study of Na alginates extracted from Sargassum spp. in relation to metal biosorption. Applied Biochemistry and Biotechnology 110(2): 75-90
Veselkov, A.N.; Baranovskiĭ, S.F.; Dymant, L.N.; Petrenko, N.V.; Osetrov, S.G.; Veselkov, D.A.; Parkes, X.; Davies, D. 1998: 1H-NMR study of complex formation between the aromatic dye ethidium bromide and the single-stranded noncomplementary deoxytetranucleotide 5'-d(CpTpGpA) in aqueous solution. Biofizika 43(2): 205-214
Ji, Z.; Yuan, H.; Liu, M.; Hu, J. 2002: 1H-NMR study of the effect of acetonitrile on the interaction of ibuprofen with human serum albumin. Journal of Pharmaceutical and Biomedical Analysis 30(1): 151-159
Petraccone, L.; Erra, E.; Nasti, L.; Galeone, A.; Randazzo, A.; Esposito, V.; Mayol, L.; Barone, G.; Giancola, C. 2003: 1H-NMR study of the quadruplex (d(TGGGT))4 containing a modified thymine. Nucleosides Nucleotides and Nucleic Acids 22(5-8): 1677-1680
Traore, A.; Foucat, L.; Renou, J.P. 2000: 1H-nmr study of water dynamics in hydrated collagen: transverse relaxation-time and diffusion analysis. Biopolymers 53(6): 476-483
Baraldi, P.-Giovanni; Cacciari, B.; Romagnoli, R.; Spalluto, G. 1999: 1H-Pyrazolo(2,3-d)(1,2,4)triazine-3,7-diones as a new class of human leukocyte elastase inhibitors. Arzneimittel-Forschung 49(12): 997-1000
Bohnenstengel, F., I.; Steube, K., G.; Meyer, C.; Quentmeier, H.; Nugroho, B., W.; Proksch, P. 1999: 1H-cyclopenta(b)benzofuran lignans from Aglaia species inhibit cell proliferation and alter cell cycle distribution in human monocytic leukemia cell lines. Zeitschrift fuer Naturforschung Section C Journal of Biosciences 54(12): 1075-1083
Giesen, A.W.; Bae, L.C.; Barrett, C.L.; Chyba, J.A.; Chaykovsky, M.M.; Cheng, M-Chang.; Murray, J.H.; Oliver, E.J.; Sullivan, S.M.; Brown, J.Miles.; Homans, S.W. 2002: 1H-filtered correlation experiments for assignment and determination of coupling constants in backbone labelled proteins. Journal of Biomolecular NMR 22(1): 21-26
Calis, I.; Kuruuzum, A.; Ruedi, P. 1999: 1H-indole-3 acetonitrile glycosides from Capparis spinosa fruits. Phytochemistry (Oxford) 50(7): 1205-1208
Henry, P.-G.; Tkác, I.; Gruetter, R. 2003: 1H-localized broadband 13C NMR spectroscopy of the rat brain in vivo at 9.4 T. Magnetic Resonance in Medicine 50(4): 684-692
Bradley, W.G.; Bowen, B.C.; Pattany, P.M.; Rotta, F. 1999: 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. Journal of the Neurological Sciences 169(1-2): 84-86
Ohtsuka, K.; Hashimoto, M. 1999: H-magnetic resonance spectroscopy of retrobulbar tissue in Graves ophthalmopathy. American Journal of Ophthalmology 128(6): 715-719
Lee, Y.; Martasek, P.; Roman, L.J.; Silverman, R.B. 2000: 1H-pyrazole-1-carboxamidines: New inhibitors of nitric oxide synthase. Bioorganic and Medicinal Chemistry Letters 10(24): 2771-2774, 18 December
Xia, Y.; Yee, A.; Arrowsmith, C.H.; Gao, X. 2003: 1H(C) and 1H(N) total NOE correlations in a single 3D NMR experiment. 15N and 13C time-sharing in t1 and t2 dimensions for simultaneous data acquisition. Journal of Biomolecular NMR 27(3): 193-203
Park, K.-J.; Choi, S.-H.; Choi, D.-H.; Park, J.-M.; Yie, S.W.; Lee, S.Y.; Hwang, S.B. 2003: 1Hepatitis C virus NS5A protein modulates c-Jun N-terminal kinase through interaction with tumor necrosis factor receptor-associated factor 2. Journal of Biological Chemistry 278(33): 30711-30718
Agramonte-Hevia, Jé.; Hallal, C.; Garay-Canales, C.; Guerra-Araiza, C.; Camacho-Arroyo, I.; Ortega Soto, E. 2003: 1alpha, 25-dihydroxy-vitamin D3 alters Syk activation through FcgammaRII in monocytic THP-1 cells. Journal of Cellular Biochemistry 89(5): 1056-1076
Saha, B.K.; Sarkar, A.; Basak, R.; Chatterjee, M. 2001: 1alpha, 25-Dihydroxyvitamin D3 suppresses the effect of streptozotocin-induced diabetes during chemical rat liver carcinogenesis. Cell Biology International 25(3): 227-237
Schwartz, Z.; Shaked, D.; Hardin, R.R.; Gruwell, S.; Dean, D.D.; Sylvia, V.L.; Boyan, B.D. 2003: 1alpha,25(OH)2D3 causes a rapid increase in phosphatidylinositol-specific PLC-beta activity via phospholipase A2-dependent production of lysophospholipid. Steroids 68(5): 423-437
Schwartz, Z.; Sylvia, V.L.; Larsson, D.; Nemere, I.; Casasola, D.; Dean, D.D.; Boyan, B.D. 2002: 1alpha,25(OH)2D3 regulates chondrocyte matrix vesicle protein kinase C (PKC) directly via G-protein-dependent mechanisms and indirectly via incorporation of PKC during matrix vesicle biogenesis. Journal of Biological Chemistry 277(14): 11828-11837
Huerta, S.; Irwin, R.W.; Heber, D.; Go, V.Liang.W.; Koeffler, H.Phillip.; Uskokovic, M.R.; Harris, D.M. 2002: 1alpha,25-(OH)(2)-D(3) and its synthetic analogue decrease tumor load in the Apc(min) Mouse. Cancer Research 62(3): 741-746
Rehan, V.K.; Torday, J.S.; Peleg, S.; Gennaro, L.; Vouros, P.; Padbury, J.; Rao, D.Sunita.; Reddy, G.Satyanarayana. 2002: 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxy vitamin D3: production and biological activity studies in pulmonary alveolar type II cells. Molecular Genetics and Metabolism 76(1): 46-56
Vazquez, G.; de Boland, A.R.; Boland, R.L. 1998: 1alpha,25-dihydroxy-vitamin-D3-induced store-operated Ca2+ influx in skeletal muscle cells. Modulation by phospholipase c, protein kinase c, and tyrosine kinases. Journal of Biological Chemistry 273(51): 33954-33960
Dam, T.N.; Kang, S.; Nickoloff, B.J.; Voorhees, J.J. 1999: 1alpha,25-dihydroxycholecalciferol and cyclosporine suppress induction and promote resolution of psoriasis in human skin grafts transplanted on to SCID mice. Journal of Investigative Dermatology 113(6): 1082-1089
Schwartz, Z.; Ehland, H.; Sylvia, V.L.; Larsson, D.; Hardin, R.R.; Bingham, V.; Lopez, D.; Dean, D.D.; Boyan, B.D. 2002: 1alpha,25-dihydroxyvitamin D(3) and 24R,25-dihydroxyvitamin D(3) modulate growth plate chondrocyte physiology via protein kinase C-dependent phosphorylation of extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase. Endocrinology 143(7): 2775-2786
Koli, K.; Keski-Oja, J. 2000: 1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth and Differentiation: the Molecular Biology Journal of the American Association for Cancer Research 11(4): 221-229
Overbergh, L.; Decallonne, B.; Waer, M.; Rutgeerts, O.; Valckx, D.; Casteels, K.M.; Laureys, J.; Bouillon, R.; Mathieu, C. 2000: 1alpha,25-Dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). Diabetes 49(8): 1301-1307
Rebsamen, M.C.; Sun, J.; Norman, A.W.; Liao, J.K. 2002: 1alpha,25-dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase. Circulation Research 91(1): 17-24
Xue, M-Lang.; Zhu, H.; Thakur, A.; Willcox, M. 2002: 1 alpha,25-Dihydroxyvitamin D3 inhibits pro-inflammatory cytokine and chemokine expression in human corneal epithelial cells colonized with Pseudomonas aeruginosa. Immunology and Cell Biology 80(4): 340-345
Zhao, X.Y.; Peehl, D.M.; Navone, N.M.; Feldman, D. 2000: 1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms. Endocrinology 141(7): 2548-2556
Saha, B.K.; Bhattacharya, R.; Chatterjee, M. 2002: 1alpha,25-Dihydroxyvitamin D(3) inhibits rat liver ultrastructural changes and the development of gamma-glutamyltranspeptidase-positive foci in diethylnitrosamine-initiated and streptozotocin-induced diabetes-promoted hepatocarcinogenesis. Cell Biochemistry and Function 20(3): 195-204
Lin, R.; Amizuka, N.; Sasaki, T.; Aarts, M.M.; Ozawa, H.; Goltzman, D.; Henderson, J.E.; White, J.H. 2002: 1Alpha,25-dihydroxyvitamin D3 promotes vascularization of the chondro-osseous junction by stimulating expression of vascular endothelial growth factor and matrix metalloproteinase 9. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 17(9): 1604-1612
Manggau, M.; Kim, D.S.; Ruwisch, L.; Vogler, R.; Korting, H.C.; Schäfer-Korting, M.; Kleuser, B. 2001: 1alpha,25-Dihydroxyvitamin D3 protects human keratinocytes from apoptosis by the formation of sphingosine-1-phosphate. Journal of Investigative Dermatology 117(5): 1241-1249
Luo, X-hang.; Liao, E-yuan. 2003: 1alpha,25-dihydroxyvitamin D3 regulates the expression of membrane-type matrix metalloproteinase-1 in normal human osteoblast-like cells. Endocrine Research 29(3): 353-362
Redaelli, C.A.; Wagner, M.; Günter-Duwe, D.; Tian, Y.-H.; Stahel, P.F.; Mazzucchelli, L.; Schmid, R.A.; Schilling, M.K. 2002: 1alpha,25-dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine a in rat renal allotransplants. Kidney International 61(1): 288-296
Berry, D.M.; Clark, C.S.; Meckling-Gill, K.A. 2002: 1alpha,25-dihydroxyvitamin D3 stimulates phosphorylation of Ikappa Balpha and synergizes with TPA to induce nuclear translocation of NFkappaB during monocytic differentiation of NB4 leukemia cells. Experimental Cell Research 272(2): 176-184
Miura, D.; Manabe, K.; Gao, Q.; Norman, A.W.; Ishizuka, S. 1999: 1alpha,25-dihydroxyvitamin D(3)-26,23-lactone analogs antagonize differentiation of human leukemia cells (HL-60 cells) but not of human acute promyelocytic leukemia cells (NB4 cells). Febs Letters 460(2): 297-302
Brown, A.J.; Ritter, C.; Slatopolsky, E.; Muralidharan, K.R.; Okamura, W.H.; Reddy, G.S. 1999: 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion. Journal of Cellular Biochemistry 73(1): 106-113
Sekimoto, H.; Siu-Caldera, M.L.; Weiskopf, A.; Vouros, P.; Muralidharan, K.R.; Okamura, W.H.; Uskokovic, M.R.; Reddy, G.S. 1999: 1alpha,25-dihydroxy-3-epi-vitamin D3: in vivo metabolite of 1alpha,25-dihydroxyvitamin D3 in rats. Febs Letters 448(2-3): 278-282
Ohsawa, M.; Koyama, T.; Yamamoto, K.; Hirosawa, S.; Kamei, S.; Kamiyama, R. 2000: 1alpha,25-dihydroxyvitamin D(3) and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL. Circulation 102(23): 2867-2872
Rashid, S.F.; Mountford, J.C.; Gombart, A.F.; Campbell, M.J. 2001: 1alpha,25-dihydroxyvitamin D(3) displays divergent growth effects in both normal and malignant cells. Steroids 66(3-5): 433-440
Johansen, C.; Iversen, L.; Ryborg, A.; Kragballe, K. 2000: 1alpha,25-dihydroxyvitamin D3 induced differentiation of cultured human keratinocytes is accompanied by a PKC-independent regulation of AP-1 DNA binding activity. Journal of Investigative Dermatology 114(6): 1174-1179
Morales, O.; Faulds, M.Hedengran.; Lindgren, U.J.; Haldosén, L-Arne. 2002: 1Alpha,25-dihydroxyvitamin D3 inhibits GH-induced expression of SOCS-3 and CIS and prolongs growth hormone signaling via the Janus kinase (JAK2)/signal transducers and activators of transcription (STAT5) system in osteoblast-like cells. Journal of Biological Chemistry 277(38): 34879-34884
Heine, G.; Anton, K.; Henz, B.M.; Worm, M. 2002: 1alpha,25-dihydroxyvitamin D3 inhibits anti-CD40 plus IL-4-mediated IgE production in vitro. European Journal of Immunology 32(12): 3395-3404
Shi, H.; Norman, A.W.; Okamura, W.H.; Sen, A.; Zemel, M.B. 2002: 1alpha,25-dihydroxyvitamin D3 inhibits uncoupling protein 2 expression in human adipocytes. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 16(13): 1808-1810
Shi, H.; Norman, A.W.; Okamura, W.H.; Sen, A.; Zemel, M.B. 2001: 1alpha,25-Dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action. FASEB Journal 15(14): 2751-2753
Johansen, C.; Kragballe, K.; Henningsen, J.; Westergaard, M.; Kristiansen, K.; Iversen, L. 2003: 1alpha,25-dihydroxyvitamin D3 stimulates activator protein 1 DNA-binding activity by a phosphatidylinositol 3-kinase/Ras/MEK/extracellular signal regulated kinase 1/2 and c-Jun N-terminal kinase 1-dependent increase in c-Fos, Fra1, and c-Jun expression in human keratinocytes. Journal of Investigative Dermatology 120(4): 561-570
Wang, S.H.; Koenig, R.J.; Giordano, T.J.; Myc, A.; Thompson, N.W.; Baker, J.R. 1999: 1Alpha,25-dihydroxyvitamin D3 up-regulates Bcl-2 expression and protects normal human thyrocytes from programmed cell death. Endocrinology 140(4): 1649-1656
Sly, L.M.; Lopez, M.; Nauseef, W.M.; Reiner, N.E. 2001: 1alpha,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. Journal of Biological Chemistry 276(38): 35482-35493
Hmama, Z.; Nandan, D.; Sly, L.; Knutson, K.L.; Herrera-Velit, P.; Reiner, N.E. 1999: 1alpha,25-dihydroxyvitamin D(3)-induced myeloid cell differentiation is regulated by a vitamin D receptor-phosphatidylinositol 3-kinase signaling complex. Journal of Experimental Medicine 190(11): 1583-1594
Kumar, R. 2002: 1Alpha,25-dihydroxyvitamin D(3) - not just a calciotropic hormone. Nephron 91(4): 576-581
Ahmed, A.F.; Dai, C.-F.; Kuo, Y.-H.; Sheu, J.-H. 2003: 1alpha,3beta,5beta-trihydroxy-24-methylenecholestan-6-one: a novel steroid from a soft coral Sinularia gibberosa. Steroids 68(4): 377-381
Yudoh, K.; Matsuno, H.; Kimura, T. 1999: 1alpha,25-dihydroxyvitamin D3 inhibits in vitro invasiveness through the extracellular matrix and in vivo pulmonary metastasis of B16 mouse melanoma. Journal of Laboratory and Clinical Medicine 133(2): 120-128
Hewison, M.; Zehnder, D.; Bland, R.; Stewart, P.M. 2000: 1alpha-Hydroxylase and the action of vitamin D. Journal of Molecular Endocrinology 25(2): 141-148
Weber, K.; Goldberg, M.; Stangassinger, M.; Erben, R.G. 2001: 1alpha-hydroxyvitamin D2 is less toxic but not bone selective relative to 1alpha-hydroxyvitamin D3 in ovariectomized rats. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 16(4): 639-651
Ichikawa, F.; Katagiri, K.; Higuchi, Y.; Takeda, S.; Saito, K. 2000: 1Alpha-hydroxyvitamin D3 prevents the decrease of bone mineral density in lactating beagles. Journal of Veterinary Medical Science 62(1): 75-79
Chattopadhyay, N.; Macleod, R.J.; Tfelt-Hansen, J.; Brown, E., M. 2003: 1alpha25(OH)2-vitamin D3 inhibits HGF synthesis and secretion from MG-63 human osteosarcoma cells. American Journal of Physiology 284(1 Part 1): E219-E227
Jacopin, C.; Laurent, M.; Belmans, M.; Kemps, L.; Ceresiat, M.; Marchand Brynaert, J. 2001: 1beta-Methylcarbapenem intermediates via the thiolysis of a Meldrum's precursor. Tetrahedron 57(52): 10383-10389, 24 December
Martínez, J.E.; Tuck-Muller, C.M.; Gasparrini, W.; Li, S.; Wertelecki, W. 1999: 1p microdeletion in sibs with minimal phenotypic manifestations. American Journal of Medical Genetics 82(2): 107-109
Hirai, M.; Yoshida, S.; Kashiwagi, H.; Kawamura, T.; Ishikawa, T.; Kaneko, M.; Ohkawa, H.; Nakagawara, A.; Miwa, M.; Uchida, K. 1999: 1q23 gain is associated with progressive neuroblastoma resistant to aggressive treatment. Genes Chromosomes and Cancer 25(3): 261-269
European-Society-For-Therapeutic-Radiology-And-Oncology 2001: 1st European Society for Therapeutic Radiology and Oncology (ESTRO) Workshop on Biology in Radiation Oncology, Fuglso, Denmark, June 10-12, 2001. Radiotherapy and Oncology 60(Suppl 2): S1-S29
Anonymous 2002: 1st International and 2nd National Workshop on Vaccine Adjuvants, Havana, Cuba, December 5-8, 2001. Biotecnologia Aplicada 19(1-2): 49-96
Dolei, A.; Palù, G. 2002: 1st SIV International Workshop on Neurovirology. Journal of Neurovirology 8(5): 470-471
Anonymous 2002: 1st Tutzing Antiphospholipid Conference, Tutzing, West Germany, April 22-25, 2002. Immunobiology 205(2): 139-185
Kuczyk, M.; Muench, T.; Bokemeyer, C.; Merseburger, A.; Wefer, A.; Kollmannsberger, C.; Kondoh, M.; Wegener, G.; Jonas, U.; Stenzl, A. 2003: 1st die Adrenalektomie unverzichtbarer Bestandteil der Tumornephrektomie? Ergebnis einer multivariaten statistischen Analyse. Der Urologe. Ausgabe A 42(3): 366-373
Omura, Y.; Shimotsuura, Y.; Ohki, M. 2003: 2 minute non-invasive screening for cardio-vascular diseases: relative limitation of C-Reactive Protein compared with more sensitive L-Homocystine as cardio-vascular risk factors; safe and effective treatment using the selective drug uptake enhancement method. Acupuncture and Electro-Therapeutics Research 28(1-2): 35-68
Klautschek, G. 1998: 2 X 2 Diallel as a concept for finding genetically based effects at the crosses of cattle (short communication). Archiv fuer Tierzucht 41(6): 583-588
Koessler, W.; Wanke, T.; Winkler, G.; Nader, A.; Toifl, K.; Kurz, H.; Zwick, H. 2001: 2 Years' experience with inspiratory muscle training in patients with neuromuscular disorders. Chest 120(3): 765-769
Leitao, S.G.; Monache, F.D.lle 1998: 2-O-caffeoylorientin from Vitex polygama. Phytochemistry 49(7): 2167-2169
Gille, A.; Seifert, R. 2003: 2'(3')-O-(N-methylanthraniloyl)-substituted GTP analogs: a novel class of potent competitive adenylyl cyclase inhibitors. Journal of Biological Chemistry 278(15): 12672-12679
Bifulco, M.; Laezza, C.; Stingo, S.; Wolff, J. 2002: 2',3'-Cyclic nucleotide 3'-phosphodiesterase: a membrane-bound, microtubule-associated protein and membrane anchor for tubulin. Proceedings of the National Academy of Sciences of the United States of America 99(4): 1807-1812
Blume, A.; Chen, H.; Reutter, W.; Schmidt, R.R.; Hinderlich, S. 2002: 2',3'-Dialdehydo-UDP-N-acetylglucosamine inhibits UDP-N-acetylglucosamine 2-epimerase, the key enzyme of sialic acid biosynthesis. FEBS Letters 521(1-3): 127-132
Lee, Y-Nan.; Yeh, H-I.; Tian, T-Yi.; Lu, W-Wei.; Ko, Y-Shien.; Tsai, C-Ho. 2002: 2',5'-Dihydroxychalcone down-regulates endothelial connexin43 gap junctions and affects MAP kinase activation. Toxicology 179(1-2): 51-60
Tatsumi, R.; Hamada, K.; Sekiya, S.; Wakamatsu, M.; Namikawa, T.; Mizutani, M.; Sokawa, Y. 2000: 2',5'-Oligoadenylate synthetase gene in chicken: Gene structure, distribution of alleles and their expression. Biochimica et Biophysica Acta 1494(3): 263-268
Maran, A.; Waller, C.F.; Paranjape, J.M.; Li, G.; Xiao, W.; Zhang, K.; Kalaycio, M.E.; Maitra, R.K.; Lichtin, A.E.; Brugger, W.; Torrence, P.F.; Silverman, R.H. 1998: 2',5'-Oligoadenylate-antisense chimeras cause RNase L to selectively degrade bcr/abl mRNA in chronic myelogenous leukemia cells. Blood 92(11): 4336-4343
Lopp, A.; Kuusksalu, A.; Reintamm, Tõnu.; Müller, W.E.G.; Kelve, M. 2002: 2',5'-oligoadenylate synthetase from a lower invertebrate, the marine sponge Geodia cydonium, does not need dsRNA for its enzymatic activity. Biochimica et Biophysica Acta 1590(1-3): 140-149
Alvino, E.; Fuggetta, M.P.; Tricarico, M.; Bonmassar, E. 1998: 2'-2'-difluorodeoxycytidine: in vitro effects on cell-mediated immune response. Anticancer Research 18(5a): 3597-3602
Behera, A.K.; Kumar, M.; Lockey, R.F.; Mohapatra, S.S. 2002: 2'-5' Oligoadenylate synthetase plays a critical role in interferon-gamma inhibition of respiratory syncytial virus infection of human epithelial cells. Journal of Biological Chemistry 277(28): 25601-25608
Turpaev, K.; Hartmann, R.; Justesen, J. 1999: 2'-Adenylated derivatives of Ap3A activate RNase L. FEBS Letters 457(1): 9-12
Von Poser, G.; Schripsema, J.; Olsen, C.E.; Henriques, A.T.; Jensen, S.R. 1998: 2'-Apiosylgardoside, an iridoid glucoside from Verbenoxzylum reitzii. Phytochemistry 49(5): 1471-1473
Rejman, D.; Masojídková, M.; De Clercq, E.; Rosenberg, I. 2001: 2'C-alkoxy and 2'-C-aryloxy derivatives of N-(2-phosphonomethoxyethyl)-purines and -pyrimidines: synthesis and biological activity. Nucleosides Nucleotides and Nucleic Acids 20(8): 1497-1522
Azuma, A.; Huang, P.; Matsuda, A.; Plunkett, W. 2001: 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine: a novel anticancer nucleoside analog that causes both DNA strand breaks and G(2) arrest. Molecular Pharmacology 59(4): 725-731
Gallo, M.; Monteagudo, E.; Cicero, D.O.; Torres, H.N.; Iribarren, A.M. 2001: 2'-C-methyluridine phosphoramidite: A new building block for the preparation of RNA analogues carrying the 2'-hydroxyl group. Tetrahedron 57(27): 5707-5713, 2 July
Khan, S.; Andralojc, P.J.; Lea, P.J.; Parry, M.A. 1999: 2'-carboxy-D-arabitinol 1-phosphate protects ribulose 1, 5-bisphosphate carboxylase/oxygenase against proteolytic breakdown. European Journal of Biochemistry 266(3): 840-847
Mikhailopulo, I.A.; Pricota, T.I.; Sivets, G.G.; Altona, C. 2003: 2'-chloro-2',3'-dideoxy-3'-fluoro-d-ribonucleosides: synthesis, stereospecificity, some chemical transformations, and conformational analysis. Journal of Organic Chemistry 68(15): 5897-5908
Jeannot, Fédéric.; Gosselin, G.; Mathé, C. 2003: 2'-Deoxy-2'-C-trifluoromethyl beta-D-ribonucleoside analogues: synthesis and antiviral evaluations. Nucleosides Nucleotides and Nucleic Acids 22(5-8): 857-859
Wilds, C.J.; Damha, M.J. 2000: 2'-Deoxy-2'-fluoro-beta-D-arabinonucleosides and oligonucleotides (2'F-ANA): Synthesis and physicochemical studies. Nucleic Acids Research 28(18): 3625-3635
Catalanotti, B.; Galeone, A.; Gomez-Paloma, L.; Mayol, L.; Pepe, A. 2000: 2'-Deoxy-8-(propyn-1-yl)adenosine-containing oligonucleotides: Effects on stability of duplex and quadruplex structures. Bioorganic and Medicinal Chemistry Letters 10(17): 2005-2009
Zhao, Z.; Crossland, W.J.; Kulkarni, J.S.; Wakade, T.D.; Wakade, A.R. 1999: 2'-Deoxyadenosine causes cell death in embryonic chicken sympathetic ganglia and brain. Cell and Tissue Research 296(2): 281-291
Adam, W.; Marquardt, S.; Kemmer, D.; Saha-Möller, C.R.; Schreier, P. 2002: 2'-Deoxyguanosine (DG) oxidation and strand-break formation in DNA by the radicals released in the photolysis of N-tert-butoxy-2-pyridone. Are tert-butoxyl or methyl radicals responsible for the photooxidative damage in aqueous media?. Organic Letters 4(2): 225-228
Veldhuyzen, W.F.; Lam, Y.F.; Rokita, S.E. 2001: 2'-Deoxyguanosine reacts with a model quinone methide at multiple sites. Chemical Research in Toxicology 14(9): 1345-1351
Von-Matt, Peter; De-Mesmaeker, Alain; Pieles, Uwe; Zurcher, Werner; Altmann, Karl-Heinz 1999: 2'-Deoxyribo-PNAs: A structurally novel class of polyamide nucleic acids with good RNA and DNA binding affinity. Tetrahedron Letters 40(15): 2899-2902
Chong, Y.; Choo, H.; Schinazi, R.F.; Chu, C.K. 2003: 2'-Fluoro-4'-thio-2',3'-unsaturated nucleosides: anti-HIV activity, resistance profile, and molecular modeling studies. Nucleosides Nucleotides and Nucleic Acids 22(5-8): 611-615
Madan, B.; Batra, S.; Ghosh, B. 2000: 2'-hydroxychalcone inhibits nuclear factor-kappaB and blocks tumor necrosis factor-alpha- and lipopolysaccharide-induced adhesion of neutrophils to human umbilical vein endothelial cells. Molecular Pharmacology 58(3): 526-534
Morita, K.; Yamate, K.; Kurakata, S-ichi.; Watanabe, K.; Imanishi, T.; Koizumi, M. 2003: 2'-O,4'-C-ethylene-bridged nucleic acid (ENA) for effective antisense formation. Nucleosides Nucleotides and Nucleic Acids 22(5-8): 1619-1621
Torigoe, H.; Hari, Y.; Sekiguchi, M.; Obika, S.; Imanishi, T. 2001: 2'-O,4'-C-methylene bridged nucleic acid modification promotes pyrimidine motif triplex DNA formation at physiological pH: thermodynamic and kinetic studies. Journal of Biological Chemistry 276(4): 2354-2360
Prakash, T., P.; Manoharan, M.; Kawasaki, A., M.; Fraser, A., S.; Lesnik, E., A.; Sioufi, N.; Leeds, J., M.; Teplova, M.; Egli, M. 2002: 2'-O-(2-(methylthio)ethyl)-modified oligonucleotide: An analogue of 2'-O-(2-(methoxy)-ethyl)-modified oligonucleotide with improved protein binding properties and high binding affinity to target RNA. Biochemistry 41(39): 11642-11648
Grotli, M.; Beijer, B.; Sproat, B. 1999: 2'-O-(carbamoylmethyl)oligoribonucleotides. Tetrahedron 55(14): 4299-4314
Prhavc, M.; Lesnik, E.A.; Mohan, V.; Manoharan, M. 2001: 2'-O-Carbamate-containing oligonucleotides: Synthesis and properties. Tetrahedron Letters 42(50): 8777-8780, 10 December
Balzarinia, J.; Degrève, B.; Zhu, C.; Durini, E.; Porcu, L.; De Clercq, E.; Karlsson, A.; Manfredini, S. 2001: 2'-O-acyl/alkyl-substituted arabinosyl nucleosides as inhibitors of human mitochondrial thymidine kinase. Biochemical Pharmacology 61(6): 727-732
Novopashina, D.; Kuznetsova, M.; Venyaminova, A. 2001: 2'-O-modified oligoribonucleotides with terminal 3'-3'-internucleotide linkage and their derivatives. Nucleosides Nucleotides and Nucleic Acids 20(4-7): 903-907
Yamana, K.; Iwase, R.; Furutani, S.; Tsuchida, H.; Zako, H.; Yamaoka, T.; Murakami, A. 1999: 2'-Pyrene modified oligonucleotide provides a highly sensitive fluorescent probe of RNA. Nucleic Acids Research 27(11): 2387-2392
el-Moselhy, T.F.; Avor, K.S.; Basmadjian, G.P. 2001: 2'-Substituted analogs of cocaine: Synthesis and dopamine transporter binding potencies. Archiv der Pharmazie 334(8-9): 275-278
Golisade, A.; Van-Calenbergh, S.; Link, A. 2000: 2'-amino-2'-deoxy-N6-(1-naphthylmethyl)adenosine as novel scaffold for a polymer-assisted amidation protocol. Tetrahedron 56(20): 3167-3172
Kamei, R.; Kadokura, M.; Kitagawa, Y.; Hazeki, O.; Oikawa, S. 2003: 2'-benzyloxychalcone derivatives stimulate glucose uptake in 3T3-L1 adipocytes. Life Sciences 73(16): 2091-2099
Roth, J.S.; McCully, C.M.; Balis, F.M.; Poplack, D.G.; Kelley, J.A. 1999: 2'-beta-fluoro-2',3'-dideoxyadenosine, lodenosine, in rhesus monkeys: plasma and cerebrospinal fluid pharmacokinetics and urinary disposition. Drug Metabolism and Disposition: the Biological Fate of Chemicals 27(10): 1128-1132
Tremblay, S.; Douki, T.; Cadet, J.; Wagner, J.R. 1999: 2'-Deoxycytidine glycols, a missing link in the free radical-mediated oxidation of DNA. Journal of Biological Chemistry 274(30): 20833-20838
Ramon, O.; Wong, H.K.; Joyeux, M.; Riondel, J.; Halimi, S.; Ravanat, J.L.; Favier, A.; Cadet, J.; Faure, P. 2001: 2'-deoxyguanosine oxidation is associated with decrease in the DNA-binding activity of the transcription factor SP1 in liver and kidney from diabetic and insulin-resistant rats. Free Radical Biology and Medicine 30(1): 107-118
Hecht, S.S.; Hochalter, J.B.; Villalta, P.W.; Murphy, S.E. 2000: 2'-Hydroxylation of nicotine by cytochrome P450 2A6 and human liver microsomes: formation of a lung carcinogen precursor. Proceedings of the National Academy of Sciences of the United States of America 97(23): 12493-12497
Krider, E.S.; Miller, J.E.; Meade, T.J.; Meade, T.J. 2002: 2'-modified nucleosides for site-specific labeling of oligonucleotides. Bioconjugate Chemistry 13(1): 155-162
Polushin, N.; Malykh, A.; Malykh, O.; Zenkova, M.; Chumakova, N.; Vlassov, V.; Kozyavkin, S. 2001: 2'-modified oligonucleotides from methoxyoxalamido and succinimido precursors: synthesis, properties, and applications. Nucleosides Nucleotides and Nucleic Acids 20(4-7): 507-514
Gruen, M.; Becker, C.; Beste, A.; Reinstein, J.; Scheidig, A.J.; Goody, R.S. 1999: 2'Halo-ATP and -GTP analogues: rational phasing tools for protein crystallography. Protein Science: a Publication of the Protein Society 8(11): 2524-2528
Dong, W.; Teraoka, H.; Kondo, S.; Hiraga, T. 2001: 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin induces apoptosis in the dorsal midbrain of zebrafish embryos by activation of arylhydrocarbon receptor. Neuroscience Letters 303(3): 169-172
Mathur, A.; Vallano, M.L. 2000: 2,2',3,3',4,4'-Hexahydroxy-1,1'-biphenyl-6,6'-dimethanol dimethyl ether (HBDDE)-induced neuronal apoptosis independent of classical protein kinase C alpha or gamma inhibition. Biochemical Pharmacology 60(6): 809-815
Waller, S.C.; He, Y.A.; Harlow, G.R.; He, Y.Q.; Mash, E.A.; Halpert, J.R. 1999: 2,2',3,3',6,6'-hexachlorobiphenyl hydroxylation by active site mutants of cytochrome P450 2B1 and 2B11. Chemical Research in Toxicology 12(8): 690-699
Foster, E., P.; Curtis, L., R. 1999: 2,2',4,4',5,5'- and 3,3',4,4',5,5'-Hexachlorobiphenyl pretreatments alter the biliary excretion of a challenge dose of 7,12-(3H)dimethylbenz(a)anthracene in rainbow trout (Oncorhyncus mykiss). Canadian Journal of Fisheries and Aquatic Sciences 56(4): 642-649
Shin, K.J.; Bae, S.S.; Hwang, Y.A.; Seo, J.K.; Ryu, S.H.; Suh, P.G. 2000: 2,2',4,6,6'-pentachlorobiphenyl induces apoptosis in human monocytic cells. Toxicology and Applied Pharmacology 169(1): 1-7
Lee, Y.Woo.; Park, H.Joo.; Son, K.Won.; Hennig, B.; Robertson, L.W.; Toborek, M. 2003: 2,2',4,6,6'-pentachlorobiphenyl (PCB 104) induces apoptosis of human microvascular endothelial cells through the caspase-dependent activation of CREB. Toxicology and Applied Pharmacology 189(1): 1-10
Arcaro, K.F.; Yi, L.; Seegal, R.F.; Vakharia, D.D.; Yang, Y.; Spink, D.C.; Brosch, K.; Gierthy, J.F. 1999: 2,2',6,6'-tetrachlorobiphenyl is estrogenic in vitro and in vivo. Journal of Cellular Biochemistry 72(1): 94-102
Miller, J.A.; Pugh, A.W.; Ullah, G.M. 2000: 2,2'-Anhydro-4'-thionucleosides: precursors for 2'-azido- and 2'-chloro-4'-thionucleosides and for a novel thiolane to thietane rearrangement. Nucleosides Nucleotides and Nucleic Acids 19(9): 1475-1486
Maruyama, K.; Nagasawa, H.; Suzuki, A. 1999: 2,2'-Bispyridyl disulfide rapidly induces intramolecular disulfide bonds in peptides. Peptides 20(7): 881-884
Wihlborg, A.K.; Slatt, J.; Sun, X.; Zhao, X.H.; Malmsjo, M.; Bergman, J.; Hedner, T.; Erlinge, D. 2003: 2,2'-Nitrophenylisatogen potentiates P2X1 receptor mediated vascular contraction and blood pressure elevation. Drug Development Research 59(1): 82-87
Halmosi, R.; Deres, P.; Toth, A.; Berente, Z.; Kalai, T.; Sumegi, B.; Hideg, K.; Toth, K. 2002: 2,2,5,5-Tetramethylpyrroline-based compounds in prevention of oxyradical-induced myocardial damage. Journal of Cardiovascular Pharmacology 40(6): 854-867
Haubmann, C.; Hübner, H.; Gmeiner, P. 1999: 2,2-Dicyanovinyl as a nonaromatic aryl bioisostere: Synthesis, binding experiments and SAR studies of highly selective dopamine D4 receptor ligands. Bioorganic and Medicinal Chemistry Letters 9(14): 1969-1972
Jiang, Y.; Zhao, J.; Hu, L. 2002: 2,2-Dimethyl-2-(o-nitrophenyl)acetyl (DMNA) as an assisted cleavage protecting group for amines. Tetrahedron Letters 43(26): 4589-4592
Shin, S.S.; Noh, M.S.; Byun, Y.J.; Choi, J.K.; Kim, J.Y.; Lim, K.M.; Ha, J.Y.; Kim, J.K.; Lee, C.H.; Chung, S. 2001: 2,2-Dimethyl-4,5-diaryl-3(2H)furanone derivatives as selective cyclo-oxygenase-2 inhibitors. Bioorganic and Medicinal Chemistry Letters 11(2): 165-168
Lee, D.S.; Kim, N.S.; Lee, S.H. 2001: 2,2-Diphenyl-1-picrylhydrazyl hydrate, a stable free radical, is an alpha-glucosidase inhibitor. Biological and Pharmaceutical Bulletin 24(6): 727-728
Bellesia, Franco; De-Buyck, Laurent; Ghelfi, Franco; Libertini, Emanuela; Pagnoni, Ugo-Maria; Roncaglia, Fabrizio 2000: 2,2-dichlorination of aldehydes with the 2,6-lutidinecntdotHCl/Cl2/CH2Cl2 system: An environmentally benign process suitable for scale up. Tetrahedron 56(38): 7507-7511, 15 September
Chang, W.-Chun; Chen, M.-Hwa; Lee, T.-Min 1999: 2,3,5-triphenyltetrazolium reduction in the viability assay of Ulva fasciata (Chlorophyta) in response to salinity stress. Botanical Bulletin of Academia Sinica (Taipei) 40(3): 207-212
Xu, L.; Li, A.P.; Kaminski, D.L.; Ruh, M.F. 2000: 2,3,7,8 tetrachlorodibenzo-p-dioxin induction of cytochrome P4501A in cultured rat and human hepatocytes. Chemico-Biological Interactions 124(3): 173-189
Son, D.S.; Ushinohama, K.; Gao, X.; Taylor, C.C.; Roby, K.F.; Rozman, K.K.; Terranova, P.F. 1999: 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) blocks ovulation by a direct action on the ovary without alteration of ovarian steroidogenesis: Lack of a direct effect on ovarian granulosa and thecal-interstitial cell steroidogenesis in vitro. Reproductive Toxicology 13(6): 521-530
Ivnitski, I.; Elmaoued, R.; Walker, M.K. 2001: 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) inhibition of coronary development is preceded by a decrease in myocyte proliferation and an increase in cardiac apoptosis. Teratology 64(4): 201-212
Davis, J.W.; Melendez, K.; Salas, V.M.; Lauer, F.T.; Burchiel, S.W. 2000: 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibits growth factor withdrawal-induced apoptosis in the human mammary epithelial cell line, MCF-10A. Carcinogenesis 21(5): 881-886
Köhle, C.; Gschaidmeier, H.; Lauth, D.; Topell, S.; Zitzer, H.; Bock, K.W. 1999: 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-mediated membrane translocation of c-Src protein kinase in liver WB-F344 cells. Archives of Toxicology 73(3): 152-158
Allen, D.E.; Leamy, L.J. 2001: 2,3,7,8-Tetrachlorodibenzo-p-dioxin affects size and shape, but not asymmetry, of mandibles in mice. Ecotoxicology 10(3): 167-176
Vorderstrasse, B.A.; Kerkvliet, N.I. 2001: 2,3,7,8-Tetrachlorodibenzo-p-dioxin affects the number and function of murine splenic dendritic cells and their expression of accessory molecules. Toxicology and Applied Pharmacology 171(2): 117-125
Pesonen, M.; Korkalainen, M.; Laitinen, J.T.; Andersson, T.B.; Vakkuri, O. 2000: 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters melatonin metabolism in fish hepatocytes. Chemico-Biological Interactions 126(3): 227-240
Loertscher, J.A.; Sattler, C.A.; Allen-Hoffmann, B.L. 2001: 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters the differentiation pattern of human keratinocytes in organotypic culture. Toxicology and Applied Pharmacology 175(2): 121-129
Laiosa, M.D.; Lai, Z-Wei.; Thurmond, T.Scott.; Fiore, N.C.; DeRossi, C.; Holdener, B.C.; Gasiewicz, T.A.; Silverstone, A.E. 2002: 2,3,7,8-tetrachlorodibenzo-p-dioxin causes alterations in lymphocyte development and thymic atrophy in hemopoietic chimeras generated from mice deficient in ARNT2. Toxicological Sciences: An Official Journal of the Society of Toxicology 69(1): 117-124
Gao, X.; Mizuyachi, K.; Terranova, P.F.; Rozman, K.K. 2001: 2,3,7,8-tetrachlorodibenzo-p-dioxin decreases responsiveness of the hypothalamus to estradiol as a feedback inducer of preovulatory gonadotropin secretion in the immature gonadotropin-primed rat. Toxicology and Applied Pharmacology 170(3): 181-190
Coady, K.K.; Jones, P.D.; Giesy, J.P. 2001: 2,3,7,8-Tetrachlorodibenzo-p-dioxin equivalents in tissue samples from three species in the Denver, Colorado, USA, metropolitan area. Environmental Toxicology and Chemistry 20(11): 2433-2442
Hurst, C.H.; Abbott, B.D.; DeVito, M.J.; Birnbaum, L.S. 1998: 2,3,7,8-Tetrachlorodibenzo-p-dioxin in pregnant Long Evans rats: disposition to maternal and embryo/fetal tissues. Toxicological Sciences: An Official Journal of the Society of Toxicology 45(2): 129-136
Toomey, B.H.; Bello, S.; Hahn, M.E.; Cantrell, S.; Wright, P.; Tillitt, D.E.; Di Giulio, R.T. 2001: 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces apoptotic cell death and cytochrome P4501A expression in developing Fundulus heteroclitus embryos. Aquatic Toxicology 53(2): 127-138
Lee, C.A.; Lawrence, B.P.; Kerkvliet, N.I.; Rifkind, A.B. 1998: 2,3,7,8-Tetrachlorodibenzo-p-dioxin induction of cytochrome P450-dependent arachidonic acid metabolism in mouse liver microsomes: evidence for species-specific differences in responses. Toxicology and Applied Pharmacology 153(1): 1-11
Theobald, H.M.; Roman, B.L.; Lin, T.M.; Ohtani, S.; Chen, S.W.; Peterson, R.E. 2000: 2,3,7,8-tetrachlorodibenzo-p-dioxin inhibits luminal cell differentiation and androgen responsiveness of the ventral prostate without inhibiting prostatic 5alpha-dihydrotestosterone formation or testicular androgen production in rat offspring. Toxicological Sciences: An Official Journal of the Society of Toxicology 58(2): 324-338
Wörner, W.; Schrenk, D. 1998: 2,3,7,8-Tetrachlorodibenzo-p-dioxin suppresses apoptosis and leads to hyperphosphorylation of p53 in rat hepatocytes. Environmental Toxicology and Pharmacology 6(4): 239-247
Teraoka, H.; Dong, W.; Ogawa, S.; Tsukiyama, S.; Okuhara, Y.; Niiyama, M.; Ueno, N.; Peterson, R.E.; Hiraga, T. 2002: 2,3,7,8-Tetrachlorodibenzo-p-dioxin toxicity in the zebrafish embryo: altered regional blood flow and impaired lower jaw development. Toxicological Sciences: An Official Journal of the Society of Toxicology 65(2): 192-199
Cheng, S-Bin.; Kuchiiwa, S.; Nagatomo, I.; Akasaki, Y.; Uchida, M.; Tominaga, M.; Hashiguchi, W.; Kuchiiwa, T.; Nakagawa, S. 2002: 2,3,7,8-Tetrachlorodibenzo-p-dioxin treatment induces c-Fos expression in the forebrain of the Long-Evans rat. Brain Research 931(2): 176-180
Dietrich, C.; Faust, D.; Budt, S.; Moskwa, M.; Kunz, A.; Bock, K-W.; Oesch, F. 2002: 2,3,7,8-Tetrachlorodibenzo-p-dioxin-dependent release from contact inhibition in WB-F344 cells: Involvement of cyclin A. Toxicology and Applied Pharmacology 183(2): 117-126
Ma, Q.; Baldwin, K.T. 2000: 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced degradation of aryl hydrocarbon receptor (AhR) by the ubiquitin-proteasome pathway. Role of the transcription activaton and DNA binding of AhR. Journal of Biological Chemistry 275(12): 8432-8438
Slezak, B.P.; Diliberto, J.J.; Birnbaum, L.S. 1999: 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated oxidative stress in CYP1A2 knockout (CYP1A2-/-) mice. Biochemical and Biophysical Research Communications 264(2): 376-379
Ferrario, J.B.; Byrne, C.J.; Cleverly, D.H. 2000: 2,3,7,8-dibenzo-p-dioxins in mined clay products from the United States: Evidence for possible natural origin. Environmental Science and Technology 34(21): 4524-4532
Crawford, R.B.; Sulentic, C.E.W.; Yoo, B.S.; Kaminski, N.E. 2003: 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation and posttranslational modification of p27kip1 in lipopolysaccharide-activated B cells. Toxicological Sciences: An Official Journal of the Society of Toxicology 75(2): 333-342
Camacho, I.A.; Nagarkatti, M.; Nagarkatti, P.S. 2002: 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces Fas-dependent activation-induced cell death in superantigen-primed T cells. Archives of Toxicology 76(10): 570-580
Shimba, S.; Hayashi, M.; Sone, H.; Yonemoto, J.; Tezuka, M. 2000: 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces binding of a 50 kDa protein on the 3' untranslated region of urokinase-type plasminogen activator mRNA. Biochemical and Biophysical Research Communications 272(2): 441-448
Ashida, H.; Nagy, S.; Matsumura, F. 2000: 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced changes in activities of nuclear protein kinases and phosphatases affecting DNA binding activity of c-Myc and AP-1 in the livers of guinea pigs. Biochemical Pharmacology 59(7): 741-751
Hornung, M.W.; Spitsbergen, J.M.; Peterson, R.E. 1999: 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters cardiovascular and craniofacial development and function in sac fry of rainbow trout (Oncorhynchus mykiss). Toxicological Sciences: An Official Journal of the Society of Toxicology 47(1): 40-51
Wagner, E.; Frank, M.M.; Smialowicz, R.J. 2001: 2,3,7,8-tetrachlorodibenzo-p-dioxin and natural immunity: Lack of an effect on the complement system in a guinea pig model. Toxicology 159(1-2): 107-113
Morán, F.M.; Conley, A.J.; Corbin, C.J.; Enan, E.; VandeVoort, C.; Overstreet, J.W.; Lasley, B.L. 2000: 2,3,7,8-tetrachlorodibenzo-p-dioxin decreases estradiol production without altering the enzyme activity of cytochrome P450 aromatase of human luteinized granulosa cells in vitro. Biology of Reproduction 62(4): 1102-1108
Nilsson, C.B.; Hoegberg, P.; Trossvik, C.; Azaïs-Braesco, V.; Blaner, W.S.; Fex, G.; Harrison, E.H.; Nau, H.; Schmidt, C.K.; van Bennekum, A.M.; Håkansson, H. 2000: 2,3,7,8-tetrachlorodibenzo-p-dioxin increases serum and kidney retinoic acid levels and kidney retinol esterification in the rat. Toxicology and Applied Pharmacology 169(2): 121-131
Dasmahapatra, A.K.; Wimpee, B.A.; Trewin, A.L.; Hutz, R.J. 2001: 2,3,7,8-Tetrachlorodibenzo-p-dioxin increases steady-state estrogen receptor-beta mRNA levels after CYP1A1 and CYP1B1 induction in rat granulosa cells in vitro. Molecular and Cellular Endocrinology 182(1): 39-48
Dong, W.; Teraoka, H.; Tsukiyama, S.; Yamazaki, K.; Imani, S.; Imagawa, T.; Kondo, S.; Hiraga, T. 2002: 2,3,7,8-tetrachlorodibenzo-p-dioxin induces apoptosis in central nervous system: Correlation between local circulation failure and apoptosis in the dorsal midbrain of zebrafish embryos. Journal of Rakuno Gakuen University Natural Science 26(2): 301-314
Hoegberg, P.; Schmidt, C.K.; Nau, H.; Ross, A.C.; Zolfaghari, R.; Fletcher, N.; Trossvik, C.; Nilsson, C.B.; Håkansson, H. 2003: 2,3,7,8-tetrachlorodibenzo-p-dioxin induces lecithin: retinol acyltransferase transcription in the rat kidney. Chemico-Biological Interactions 145(1): 1-16
Murayama, T.; Inoue, M.; Nomura, T.; Mori, S.; Eizuru, Y. 2002: 2,3,7,8-tetrachlorodibenzo-p-dioxin is a possible activator of human cytomegalovirus replication in a human fibroblast cell line. Biochemical and Biophysical Research Communications 296(3): 651-656
Ruby, C.E.; Leid, M.; Kerkvliet, N.I. 2002: 2,3,7,8-Tetrachlorodibenzo-p-dioxin suppresses tumor necrosis factor-alpha and anti-CD40-induced activation of NF-kappaB/Rel in dendritic cells: p50 homodimer activation is not affected. Molecular Pharmacology 62(3): 722-728
Davis, C.R.; Allen, D.E.; Leamy, L.J. 2002: 2,3,7,8-Tetrachlorodibenzo-p-dioxin: its effect on genes for mandible traits in mice. Environmental Toxicology and Pharmacology 12(1): 43-53
Gadikota, R.R.; Callam, C.S.; Wagner, T.; Del Fraino, B.; Lowary, T.L. 2003: 2,3-Anhydro sugars in glycoside bond synthesis. Highly stereoselective syntheses of oligosaccharides containing alpha- and beta-arabinofuranosyl linkages. Journal of the American Chemical Society 125(14): 4155-4165
Perego, P.; Converti, A.; Del Borghi, A.; Canepa, P. 2000: 2,3-Butanediol production by Enterobacter aerogenes: Selection of the optimal conditions and application to food industry residues. Bioprocess Engineering 23(6): 613-620
Castillo, A.M.; Reyes, Jé.Luis.; Sánchez, E.; Mondragón, R.; Meza, I. 2002: 2,3-Butanedione monoxime (BDM), a potent inhibitor of actin-myosin interaction, induces ion and fluid transport in MDCK monolayers. Journal of Muscle Research and Cell Motility 23(3): 223-234
Jayawant, A.M.; Stephenson, E.R.; Damiano, R.J. 1999: 2,3-Butanedione monoxime cardioplegia: Advantages over hyperkalemia in blood-perfused isolated hearts. Annals of Thoracic Surgery 67(3): 618-623
Sun, Y.B.; Lou, F.; Edman, K.A. 2001: 2,3-Butanedione monoxime increases speed of relaxation in single muscle fibres of frog. Acta Physiologica Scandinavica 172(1): 53-61
Pomponi, M.; Bertonati, C.; Fuglei, E.; Wiig, O.; Derocher, A.E. 2000: 2,3-DPG-Hb complex: A hypothesis for an asymmetric binding. Biophysical Chemistry 84(3): 253-260
Kim, Y.; You, Y-Jae.; Nam, N-Hai.; Ahn, B-Zun. 2002: 2,3-dibenzylbutyrolactones and 1,2,3,4-tetrahydro-2-naphthoic acid gamma-lactones: structure and activity relationship in cytotoxic activity. Archives of Pharmacal Research 25(3): 240-249
Wheeler, J., W.; Ibrahim, S., A.; Weldon, P., J. 1999: 2,3-Dihydrofarnesyl and citronellyl esters in the paracloacal gland secretions of the brown caiman (Caiman crocodilus fuscus) from Costa Rica. Biochemical Systematics and Ecology 27(1): 27-32
Clayden, J.; Menet, C.J. 2003: 2,3-Dihydroisoindolones by cyclisation and rearomatisation of lithiated benzamides. Tetrahedron Letters 44(15): 3059-3062, 7 April
Diab, Y.; Dolmazon, R.; Fenet, B. 2001: 2,3-alpha-Epoxyjaeschkeanadiol 5-benzoate from Ferula hermonis Boiss. Flavour and Fragrance Journal 16(6): 397-400
Maesako, M.; Araki, J.; Lee, S.; Doi, Y.; Imaoka, T.; Iribe, G.; Mohri, S.; Hirakawa, M.; Harada, M.; Suga, H. 2000: 2,3-Butanedione monoxime suppresses primarily total calcium handling in canine heart. Japanese Journal of Physiology 50(5): 543-551
Hyup, Y.Hyup.; Kwan, J.Kwan.; Kang, S-Hwa.; Noh, M-Soo.; Ha, J-Yong.; Kyu, J.Kyu.; Min, K.Min.; Hoon, C.Hoon.; Chung, S. 2003: 2,3-diarylbenzopyran derivatives as a novel class of selective cyclooxygenase-2 inhibitors. Bioorganic and Medicinal Chemistry Letters 13(3): 413-417
Black, W.C.; Brideau, C.; Chan, C.C.; Charleson, S.; Chauret, N.; Claveau, D.; Ethier, D.; Gordon, R.; Greig, G.; Guay, J.; Hughes, G.; Jolicoeur, P.; Leblanc, Y.; Nicoll-Griffith, D.; Ouimet, N.; Riendeau, D.; Visco, D.; Wang, Z.; Xu, L.; Prasit, P. 1999: 2,3-Diarylcyclopentenones as orally active, highly selective cyclooxygenase-2 inhibitors. Journal of Medicinal Chemistry 42(7): 1274-1281
Tapia, I.; Alonso-Cires, L.; López-Tudanca, P.L.; Mosquera, R.; Labeaga, L.; Innerárity, A.; Orjales, A. 1999: 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives. Journal of Medicinal Chemistry 42(15): 2870-2880
Nascimento, I.R.; Lopes, L.M.X. 1999: 2,3-dihydrobenzofuran neolignans from Aristolochia pubescens. Phytochemistry 52(2): 345-350
Quinhones, E.B.; Souza, D.O.; Rocha, J.B. 2001: 2,3-dimercaptopropanol inhibits Ca2+ transport in microsomes from brain but not from fast-skeletal muscle. Neurochemical Research 26(3): 251-256
Tentschert, J.; Bestmann, H.J.; Hölldobler, B.; Heinze, J. 2000: 2,3-dimethyl-5-(2-methylpropyl)pyrazine, a trail pheromone component of Eutetramorium mocquerysi Emery (1899) (Hymenoptera: Formicidae). Die Naturwissenschaften 87(8): 377-380
Sakamuri, S.; Enyedy, I.J.; Zaman, W.A.; Tella, S.R.; Kozikowski, A.P.; Flippen-Anderson, J.L.; Farkas, T.; Johnson, K.M.; Wang, S. 2003: 2,3-disubstituted quinuclidines as a novel class of dopamine transporter inhibitors. Bioorganic and Medicinal Chemistry 11(6): 1123-1136
Hopper, D.J.; Kaderbhai, M.A. 1999: 2,4'-Dihydroxyacetophenone dioxygenase (EC from Alcaligenes sp. 4HAP: a novel enzyme with an atypical dioxygenase sequence. Biochemical Journal 344 Pt 2: 397-402
Oakley, G.G.; Roe, A.L.; Blouin, R.A.; Twaroski, T.P.; Ganguly, T.C.; Vore, M.; Lehmler, H.J.; Robertson, L.W. 2001: 2,4,4'-trichlorobiphenyl increases STAT5 transcriptional activity. Molecular Carcinogenesis 30(4): 199-208
Yamanoshita, O.; Saito, T.; Takahashi, K.; Hosokawa, T.; Okabe, M.; Ito, K.; Kurasaki, M. 2001: 2,4,5-Trichlorophenoxyacetic acid inhibits apoptosis in PC12 cells. Life Sciences 69(4): 403-408
Zhang, C.; Sarshar, S.; Moran, E.J.; Krane, S.; Rodarte, J.C.; Benbatoul, K.D.; Dixon, R.; Mjalli, A.M. 2000: 2,4,5-Trisubstituted imidazoles: novel nontoxic modulators of P-glycoprotein mediated multidrug resistance. Part 2. Bioorganic and Medicinal Chemistry Letters 10(23): 2603-2605
Chaikovski, V.K.; Filimonov, V.D.; Yagovkin, A.Y.; Kharlova, T.S. 2000: 2,4,6,8-Tetraiodoglycoluril in sulfuric acid as a new powerful reagent for iodination of deactivated arenes. Tetrahedron Letters 41(47): 9101-9104, 18 November
Leonard, K.A.; Nelen, M.I.; Anderson, L.T.; Gibson, S.L.; Hilf, R.; Detty, M.R. 1999: 2,4,6-Triarylchalcogenopyrylium dyes related in structure to the antitumor agent AA1 as in vitro sensitizers for the photodynamic therapy of cancer. Journal of Medicinal Chemistry 42(19): 3942-3952
Domínguez, V.M.; Correa, J.; Vidal, G.; López, A.; Martínez, M. 2002: 2,4,6-trichlorophenol degradation by river sediment exposed to bleached kraft mill discharge. Bulletin of Environmental Contamination and Toxicology 69(4): 463-470
Watrous, M.M.; Clark, S.; Kutty, R.; Huang, S.; Rudolph, F.B.; Hughes, J.B.; Bennett, G.N. 2003: 2,4,6-trinitrotoluene reduction by an Fe-only hydrogenase in Clostridium acetobutylicum. Applied and Environmental Microbiology 69(3): 1542-1547
Huang, S.; Lindahl, P.A.; Wang, C.; Bennett, G.N.; Rudolph, F.B.; Hughes, J.B. 2000: 2,4,6-trinitrotoluene reduction by carbon monoxide dehydrogenase from Clostridium thermoaceticum. Applied and Environmental Microbiology 66(4): 1474-1478
Girona, J.; Vallvé, J.C.; Ribalta, J.; Heras, M.; Olivé, S.; Masana, L. 2001: 2,4-Decadienal downregulates TNF-alpha gene expression in THP-1 human macrophages. Atherosclerosis 158(1): 95-101
Akakabe, Y.; Matsui, K.; Kajiwara, T. 2003: 2,4-Decadienals are produced via (R)-11-HPITE from arachidonic acid in marine green alga Ulva conglobata. Bioorganic and Medicinal Chemistry 11(17): 3607-3609
Micheli, F.; Di Fabio, R.; Bordi, F.; Cavallini, P.; Cavanni, P.; Donati, D.; Faedo, S.; Maffeis, M.; Sabbatini, F.Maria.; Tarzia, G.; Tranquillini, M.Elvira. 2003: 2,4-Dicarboxy-pyrroles as selective non-competitive mGluR1 antagonists: Further characterization of 3,5-dimethyl pyrrole-2,4-dicarboxylic acid 2-propyl ester 4-(1,2,2-trimethyl-propyl) ester and structure-activity relationships. Bioorganic and Medicinal Chemistry Letters 13(13): 2113-2118
Poh, R.; Xia, X.; Bruce, I.J.; Smith, A.R. 2001: 2,4-dichlorophenoxyacetate/alpha-ketoglutarate dioxygenases from Burkholderia cepacia 2a and Ralstonia eutropha JMP134. Microbios 105(410): 43-63
Rosso, S.B.; Cáceres, A.O.; de Duffard, A.M.; Duffard, R.O.; Quiroga, S. 2000: 2,4-Dichlorophenoxyacetic acid disrupts the cytoskeleton and disorganizes the Golgi apparatus of cultured neurons. Toxicological Sciences: An Official Journal of the Society of Toxicology 56(1): 133-140
Arbuckle, T.E.; Schrader, S.M.; Cole, D.; Hall, J.C.; Bancej, C.M.; Turner, L.A.; Claman, P. 1999: 2,4-Dichlorophenoxyacetic acid residues in semen of Ontario farmers. Reproductive Toxicology 13(6): 421-429
Perez Martinez, J.I.; Gines, J.M.; Morillo, E.; Rodriguez, M.L.G.; Moyano, J.R. 2000: 2,4-Dichlorophenoxyacetic acid/partially methylated-beta-Cyclodextrin inclusion complexes. Environmental Technology 21(2): 209-216
Liang, X.; Thorpe, C.; Schulz, H. 2000: 2,4-Dienoyl-CoA reductase from Escherichia coli is a novel iron-sulfur flavoprotein that functions in fatty acid beta-oxidation. Archives of Biochemistry and Biophysics 380(2): 373-379
Kelly, N.M.; Jensen, K.J. 2001: 2,4-Dimethoxybenzyl: An amide protecting group for 2-acetamido glycosyl donors. Journal of Carbohydrate Chemistry 20(7-8): 537-548
Dabkowski, W.; Tworowska, I.; Michalski, J.; Cramer, F. 2000: 2,4-Dinitrophenol: A novel activating reagent in nucleotide synthesis via the phosphoramidite route. Design of new effective phosphitylating reagents. Tetrahedron Letters 41(39): 7535-7539, 23 September
Stefek, M.; Trnkova, Z.; Krizanova, L. 1999: 2,4-dinitrophenylhydrazine carbonyl assay in metal-catalysed protein glycoxidation. Redox Report: Communications in Free Radical Research 4(1-2): 43-48
Manley, P.J.; Balitza, A.E.; Bilodeau, M.T.; Coll, K.E.; Hartman, G.D.; Mcfall, R.C.; Rickert, K.W.; Rodman, L.D.; Thomas, K.A. 2003: 2,4-Disubstituted pyrimidines: A novel class of KDR kinase inhibitors. Bioorganic and Medicinal Chemistry Letters 13(10): 1673-1677
Bergauer, M.; Hübner, H.; Gmeiner, P. 2002: 2,4-Disubstituted pyrroles: Synthesis, traceless linking and pharmacological investigations leading to the dopamine D4 receptor partial agonist FAUC 356. Bioorganic and Medicinal Chemistry Letters 12(15): 1937-1940
Vergnes, J.S.; Ballantyne, B. 2000: 2,4-Pentanedione: Evaluation of the genotoxic potential in vitro and in vivo. Toxic Substance Mechanisms 19(3): 151-175
Hu, B.; Ellingboe, J.; Gunawan, I.; Han, S.; Largis, E.; Li, Z.; Malamas, M.; Mulvey, R.; Oliphant, A.; Sum, F.W.; Tillett, J.; Wong, V. 2001: 2,4-Thiazolidinediones as potent and selective human beta3 agonists. Bioorganic and Medicinal Chemistry Letters 11(6): 757-760
Mráz, J.; Bousková, S. 1999: 2,4-Toluenediisocyanate and hexamethylene-diisocyanate adducts with blood proteins: Assessment of reactivity of amino acid residues in vitro. Chemico-Biological Interactions 117(2): 173-186
Van Tilburg, E.W.; von Frijtag Drabbe Kunzel, J.; de Groote, M.; IJzerman, A.P. 2002: 2,5'-Disubstituted adenosine derivatives: evaluation of selectivity and efficacy for the adenosine A(1), A(2A), and A(3) receptor. Journal of Medicinal Chemistry 45(2): 420-429
Chakraborty, T.K.; Ghosh, S.; Rao, M.H.V.R.mana; Kunwar, A.C.; Cho, H.; Ghosh, A.K. 2000: 2,5-Anhydro sugar diacid and 2,5-anhydro sugar diamine based C2 symmetric peptidomimetics as potential HIV-1 protease inhibitors. Tetrahedron Letters 41(51): 10121-10125, 16 December
Rawson, N.E.; Ji, H.; Friedman, M.I. 2003: 2,5-Anhydro-D-mannitol increases hepatocyte calcium: Implications for a hepatic hunger stimulus. Biochimica et Biophysica Acta 1642(1-2): 59-66
Friedman, M.I.; Graczyk-Millbrandt, G.; Ji, H.; Rawson, N.E.; Osbakken, M.D. 2003: 2,5-Anhydro-D-mannitol increases hepatocyte sodium: Transduction of a hepatic hunger stimulus?. Biochimica et Biophysica Acta 1642(1-2): 53-58
Hillaert, U.; Baert, K.; Rozenski, J.; Croubels, S.; De Keukeleire, D.; De Backer, P.; Van Calenbergh, S. 2003: 2,5-Bis-(2-hydroxybenzoylamino)pentanoic acid, a salicylic acid-metabolite isolated from chicken: Characterization and independent synthesis. Bioorganic and Medicinal Chemistry Letters 13(3): 335-337
Fusi, F.; Valoti, M.; Frosini, M.; Sgaragli, G.P. 1999: 2,5-Di-t-butyl-1,4-benzohydroquinone induces endothelium-dependent relaxation of rat thoracic aorta. European Journal of Pharmacology 366(2-3): 181-187
Sakai, A.; Teshima, R. 2001: 2,5-Di-tert-butyl-1,4-hydroquinone enhances cell transformation accompanied by an increase in intracellular free calcium ion concentration. Cancer Letters 168(2): 183-190
Zabetakis, I.; Gramshaw, J.W.; Robinson, D.S. 1999: 2,5-Dimethyl-4-hydroxy-2H-furan-3-one and its derivatives: Analysis, synthesis and biosynthesis-A review. Food Chemistry 65(2): 139-151
Lee, J.; Shim, H.; Park, Y.; Park, S.; Shin, J.; Yang, W.; Lee, H.; Park, W.; Chung, Y.; Lee, S. 2002: 2,5-Pyridinedicarboxylic acid derivatives as non-nucleosidic reverse transcriptase inhibitors of hepatitis B virus. Bioorganic and Medicinal Chemistry Letters 12(19): 2715-2717
Dolich, M.O.; McKenney, M.G.; Varela, J.E.; Compton, R.P.; McKenney, K.L.; Cohn, S.M. 2001: 2,576 ultrasounds for blunt abdominal trauma. Journal of Trauma 50(1): 108-112
Moravec, Jí.; Krystof, Vír.; Hanus, J.; Havlícek, L.; Moravcová, D.; Fuksová, K.; Kuzma, M.; Lenobel, Ré.; Otyepka, M.; Strnad, M. 2003: 2,6,8,9-Tetrasubstituted purines as new CDK1 inhibitors. Bioorganic and Medicinal Chemistry Letters 13(18): 2993-2996
Imbach, P.; Capraro, H.G.; Furet, P.; Mett, H.; Meyer, T.; Zimmermann, J. 1999: 2,6,9-trisubstituted purines: Optimization towards highly potent and selective CDK1 inhibitors. Bioorganic and Medicinal Chemistry Letters 9(1): 91-96
Wang, Z.; Huynh, H.K.; Han, B.; Krishnamurthy, R.; Eschenmoser, A. 2003: 2,6-Diamino-5,8-diaza-7,9-dicarba-purine. Organic Letters 5(12): 2067-2070
Mohamed, G.G.; Khalil, S.M.; Zayed, M.A.; El-Shall, M.Abd.El-Hamid. 2002: 2,6-Dichloroquinone chlorimide and 7,7,8,8-tetracyanoquinodimethane reagents for the spectrophotometric determination of salbutamol in pure and dosage forms. Journal of Pharmaceutical and Biomedical Analysis 28(6): 1127-1133
Harrison, B.A.; Pasternak, G.W.; Verdine, G.L. 2003: 2,6-Dimethyltyrosine analogues of a stereodiversified ligand library: highly potent, selective, non-peptidic mu opioid receptor agonists. Journal of Medicinal Chemistry 46(5): 677-680
Wu, X.; Delgado, G.; Krishnamurthy, R.; Eschenmoser, A. 2002: 2,6-diaminopurine in TNA: effect on duplex stabilities and on the efficiency of template-controlled ligations. Organic Letters 4(8): 1283-1286
Kumar, S.; Acharya, S.K. 1999: 2,6-Dichloro-phenol indophenol prevents switch-over of electrons between the cyanide-sensitive and -insensitive pathway of the mitochondrial electron transport chain in the presence of inhibitors. Analytical Biochemistry 268(1): 89-93
Qiu, J.; Stevenson, S.H.; O'Beirne, M.J.; Silverman, R.B. 1999: 2,6-Difluorophenol as a bioisostere of a carboxylic acid: bioisosteric analogues of gamma-aminobutyric acid. Journal of Medicinal Chemistry 42(2): 329-332
Hollick, J.J.; Golding, B.T.; Hardcastle, I.R.; Martin, N.; Richardson, C.; Rigoreau, L.J.M.; Smith, G.C.M.; Griffin, R.J. 2003: 2,6-disubstituted pyran-4-one and thiopyran-4-one inhibitors of DNA-Dependent protein kinase (DNA-PK). Bioorganic and Medicinal Chemistry Letters 13(18): 3083-3086
Chen, Z.-Long; Wang, W.-Qing; Cheng, J.-Rong; Xu, D.-Yu 1998: 2,7,12,18-Tetramethyl-13,17-di(3-hydroxypropyl)porphyrin: Synthesis and photosensitivity. Zhongguo Yiyao Gongye Zazhi 29(11): 501-502
Chinchilla, R.; Dodsworth, D.J.; Nájera, C.; Soriano, Jé.M. 2002: 2,7-Di-tert-butyl-Fmoc-P-OSu: A new polymer-supported reagent for the protection of the amino group. Bioorganic and Medicinal Chemistry Letters 12(14): 1817-1820
Jakubowski, W.; Bartosz, G. 2000: 2,7-dichlorofluorescin oxidation and reactive oxygen species: what does it measure?. Cell Biology International 24(10): 757-760
Perry, P.J.; Read, M.A.; Davies, R.T.; Gowan, S.M.; Reszka, A.P.; Wood, A.A.; Kelland, L.R.; Neidle, S. 1999: 2,7-Disubstituted amidofluorenone derivatives as inhibitors of human telomerase. Journal of Medicinal Chemistry 42(14): 2679-2684
van Tilburg, E.W.; Gremmen, M.; von Frijtag Drabbe Künzel, J.; de Groote, M.; IJzerman, A.P. 2003: 2,8-Disubstituted adenosine derivatives as partial agonists for the adenosine A2A receptor. Bioorganic and Medicinal Chemistry 11(10): 2183-2192
Ohne, T.; Fujito, A.; Koga, K.; Imaide, Y.; Uchida, M. 1998: 2,8-dihydroxyadenine urolithiasis due to partial deficiency of adenine phosphoribosyltransferase: a case report. Hinyokika Kiyo. Acta Urologica Japonica 44(10): 725-728
Deng, L.; Yang, M.; Fründ, S.; Wessel, T.; De Abreu, R.A.; Tischfield, J.A.; Sahota, A. 2001: 2,8-Dihydroxyadenine urolithiasis in a patient with considerable residual adenine phosphoribosyltransferase activity in cell extracts but with mutations in both copies of APRT. Molecular Genetics and Metabolism 72(3): 260-264
Salmon-Chemin, L.; Buisine, E.; Yardley, V.; Kohler, S.; Debreu, M.A.; Landry, V.; Sergheraert, C.; Croft, S.L.; Krauth-Siegel, R.L.; Davioud-Charvet, E. 2001: 2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity. Journal of Medicinal Chemistry 44(4): 548-565
Chae, G.H.; Song, G.Y.; Kim, Y.; Cho, H.; Sok, D.E.; Ahn, B.Z. 1999: 2- or 6-(1-azidoalkyl)-5,8-dimethoxy-1,4-naphthoquinone: Synthesis, evaluation of cytotoxic activity, antitumor activity and inhibitory effect on DNA topoisomerase-I. Archives of Pharmacal Research 22(5): 507-514
Oya, S.; Choi, S.R.; Hou, C.; Mu, M.; Kung, M.P.; Acton, P.D.; Siciliano, M.; Kung, H.F. 2000: 2-((2-((Dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): An improved serotonin transporter ligand. Nuclear Medicine and Biology 27(3): 249-254
Tam, M.N.; Nam, N.H.; Jin, G.Z.; Ahn, B.Z. 2000: 2-(1 -hydroxyiminoalkyl)-1 ,4-dimethoxy-9,10-anthraquinones: synthesis and evaluation of cytotoxicity. Archives of Pharmacal Research 23(4): 283-287
Dolci, L.; Dolle, F.; Jubeau, S.; Vaufrey, F.; Crouzel, C. 1999: 2-(18F)fluoropyridines by no-carrier-added nucleophilic aromatic substitution with (18F)FK-K222: A comparative study. Journal of Labelled Compounds and Radiopharmaceuticals 42(10): 975-985
Mackman, R.L.; Hui, H.C.; Breitenbucher, J.Guy.; Katz, B.A.; Luong, C.; Martelli, A.; McGee, D.; Radika, K.; Sendzik, M.; Spencer, J.R.; Sprengeler, P.A.; Tario, J.; Verner, E.; Wang, J. 2002: 2-(2-Hydroxy-3-alkoxyphenyl)-1H-benzimidazole-5-carboxamidine derivatives as potent and selective urokinase-type plasminogen activator inhibitors. Bioorganic and Medicinal Chemistry Letters 12(15): 2019-2022
Efange, S.M.; Tu, Z.; von Hohenberg, K.; Francesconi, L.; Howell, R.C.; Rampersad, M.V.; Todaro, L.J.; Papke, R.L.; Kung, M.P. 2001: 2-(2-Piperidyl)- and 2-(2-pyrrolidyl)chromans as nicotine agonists: Synthesis and preliminary pharmacological characterization. Journal of Medicinal Chemistry 44(26): 4704-4715
Büttelmann, B.; Alanine, A.; Bourson, A.; Gill, R.; Heitz, M-Paule.; Mutel, V.; Pinard, E.; Trube, G.; Wyler, Ré. 2003: 2-(3,4-Dihydro-1H-isoquinolin-2yl)-pyridines as a novel class of NR1/2B subtype selective NMDA receptor antagonists. Bioorganic and Medicinal Chemistry Letters 13(5): 829-832
Lin, P.; Marino, D.; Lo, J.L.; Yang, Y.T.; Cheng, K.; Smith, R.G.; Fisher, M.H.; Wyvratt, M.J.; Goulet, M.T. 2001: 2-(3,5-Dimethylphenyl)tryptamine derivatives that bind to the GnRH receptor. Bioorganic and Medicinal Chemistry Letters 11(8): 1073-1076
Guo, M.-Jun; Varady, L. 2002: 2-(3-aminopropyl)-4-pentenoic acid as a bio-compatible/cleavable linker for solid-phase organic synthesis. Tetrahedron Letters 43(20): 3677-3680
Husain, S.S.; Ziebell, M.R.; Ruesch, D.; Hong, F.; Arevalo, E.; Kosterlitz, J.A.; Olsen, R.W.; Forman, S.A.; Cohen, J.B.; Miller, K.W. 2003: 2-(3-Methyl-3H-diaziren-3-yl)ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate: a derivative of the stereoselective general anesthetic etomidate for photolabeling ligand-gated ion channels. Journal of Medicinal Chemistry 46(7): 1257-1265
Suzuki, T.; Nagaoka, H.; Kondo, Y.; Takahashi, T.; Takeuchi, M.; Hara, H.; Saito, M.; Yamada, T.; Tomioka, K.; Hamada, M.; Mase, T. 1998: 2-(3-Pyridyl)thiazolidine-4-carboxamide derivatives. II. Structure-activity relationships and active configuration of 2-(3-pyridyl)thiazolidine-4-carboxamides as platelet-activating factor receptor antagonists. Chemical and Pharmaceutical Bulletin 46(9): 1468-1473
Suzuki, T.; Nagaoka, H.; Hara, H.; Takeuchi, M.; Saito, M.; Yamada, T.; Tomioka, K.; Matsumoto, H.; Takanuki, K.; Mase, T. 1999: 2-(3-Pyridyl)thiazolidine-4-carboxamide derivatives. III.) Synthesis of metabolites and metabolism of 2-(3-pyridyl)thiazolidine-4-carboxamides YM461 and YM264 as platelet-activating factor (PAF) receptor antagonists. Chemical and Pharmaceutical Bulletin 47(2): 165-170
Sparatore, A.; Sparatore, F. 2000: 2-(4-(omega-(4-(2-methoxyphenyl)-1-piperazinyl)alkoxy)phenyl) phthalimides as ligands for some 5-HT, dopamine and adrenergic receptor subtypes. Pharmacy and Pharmacology Communications 6(12): 559-562
Sparatore, A.; Sparatore, F. 2000: 2-(4-(omega-(4-(2-methoxyphenyl)-1-piperazinyl)alkoxy)phenyl)-2H-benzotriazoles and their N-oxides as ligands for some 5-hydroxytryptamine, dopamine and adrenergic receptor subtypes. Pharmacy and Pharmacology Communications 6(9): 421-425
Assaf, P.; Katzhendler, J.; Haj-Yehia, A.I. 2000: 2-(4-Carboxyphenyl)-6-N,N-diethylaminobenzofuran: a useful reagent for the sensitive determination of alcohols by high-performance liquid chromatography with fluorimetric detection. Journal of Chromatography A 869(1-2): 243-250
Jung, Y.D.; Kim, M.S.; Lee, K.S.; Kang, I.C.; Nah, A.S.; Song, D.U.; Yang, S.Y.; Kim, J.K.; Ahn, B.W. 1999: 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002) inhibits nitric oxide production in cultured murine astrocytes. Pharmacological Research 40(5): 423-427
Menicagli, R.; Samaritani, S.; Gori, S. 1999: 2-(Alk-1'-ynyl)-4,6-dimethoxy-1,3,5-triazines via Pd-mediated alkynylation of 2-chloro-4,6-dimethoxy-1,3,5-triazine. Tetrahedron Letters 40(48): 8419-8422
Boyd, H.F.; Flynn, S.T.; Hickey, D.M.; Ife, R.J.; Jones, M.; Leach, C.A.; Macphee, C.H.; Milliner, K.J.; Rawlings, D.A.; Slingsby, B.P.; Smith, S.A.; Stansfield, I.G.; Tew, D.G.; Theobald, C.J. 2000: 2-(Alkylthio)pyrimidin-4-ones as novel, reversible inhibitors of lipoprotein-associated phospholipase A2. Bioorganic and Medicinal Chemistry Letters 10(4): 395-398
Ha, T.G.; Jang, J.J.; Kim, S.G.; Kim, N.D. 1999: 2-(Allylthio)pyrazine inhibition of aflatoxin B1-induced hepatocarcinogenesis in rats. Chemico-Biological Interactions 121(2): 209-222
Kang, K.W.; Ha, J.R.; Kim, C.W.; Kim, N.D.; Kim, S.G. 2001: 2-(Allylthio)pyrazine, a cancer chemopreventive agent, inhibits liver fibrosis induced by dimethylnitrosamine in rats: role of inhibition of transforming growth factor-beta1 expression. Pharmacology and Toxicology 89(1): 23-29
Hodson, S.J.; Bishop, M.J.; Speake, J.D.; Navas, F.; Garrison, D.T.; Bigham, E.C.; Saussy, D.L.; Liacos, J.A.; Irving, P.E.; Gobel, M.Jeffrey.; Sherman, B.W. 2002: 2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues. Journal of Medicinal Chemistry 45(11): 2229-2239
Speake, J.D.; Navas, F.; Bishop, M.J.; Garrison, D.T.; Bigham, E.C.; Hodson, S.J.; Saussy, D.L.; Liacos, J.A.; Irving, P.E.; Sherman, B.W. 2003: 2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds. Bioorganic and Medicinal Chemistry Letters 13(6): 1183-1186
Bishop, M.J.; Berman, J.; Bigham, E.C.; Garrison, D.T.; Gobel, M.J.; Hodson, S.J.; Irving, P.E.; Liacos, J.A.; Minick, D.J.; Navas, F.; Saussy, D.L.; Speake, J.D. 2001: 2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides. Bioorganic and Medicinal Chemistry Letters 11(21): 2871-2874
Wada, T.; Ohkubo, A.; Mochizuki, A.; Sekine, M. 2001: 2-(Azidomethyl)benzoyl as a new protecting group in nucleosides. Tetrahedron Letters 42(6): 1069-1072
Andrés, J.Ignacio.; Alonso, Jé.M.; Fernández, J.; Iturrino, L.; Martínez, P.; Meert, T.F.; Sipido, V.K. 2002: 2-(Dimethylaminomethyl)-tetrahydroisoxazolopyridobenzazepine derivatives. Synthesis of a new 5-HT(2C) antagonist with potential anxiolytic properties. Bioorganic and Medicinal Chemistry Letters 12(24): 3573-3577
Singh, G.; Singh, L.; Ishar, M.P.S. 2002: 2-(N-methylanilino)-3-formylchromone: A versatile synthon for incorporation of chromone moiety in a variety of heterocyclic systems and macrocycles through reactions with bifunctional nucleophiles. Tetrahedron 58(39): 7883-7890
Andersen, H.S.; Iversen, L.F.; Jeppesen, C.B.; Branner, S.; Norris, K.; Rasmussen, H.B.; Møller, K.B.; Møller, N.P. 2000: 2-(oxalylamino)-benzoic acid is a general, competitive inhibitor of protein-tyrosine phosphatases. Journal of Biological Chemistry 275(10): 7101-7108
Navas, F.; Bishop, M.J.; Garrison, D.T.; Hodson, S.J.; Speake, J.D.; Bigham, E.C.; Drewry, D.H.; Saussy, D.L.; Liacos, J.H.; Irving, P.E.; Gobel, M.Jeffrey. 2002: 2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series. Bioorganic and Medicinal Chemistry Letters 12(4): 575-579
Perrone, R.; Berardi, F.; Colabufo, N., A.; Leopoldo, M.; Tortorella, V. 1999: 2-(aryloxy)ethylamine derivatives: Ring opened congeners of long chain 1-arylpiperazines with high 5-HT1A receptor affinity and selectivity versus D2 and alpha1 receptors. Medicinal Chemistry Research 9(5): 340-353
Anilkumar, R.; Chandrasekhar, S.; Sridhar, M. 2000: 2-(ethoxycarbonylmethyl)-1H-naphtho(1,8-de)-1,2,3-triazine anion: A new glycine enolate equivalent. Tetrahedron Letters 41(34): 6665-6668
Al-Essa, M.; Al-Hussein, K.; Ozand, P., T. 1999: 2-(fluorine-18) fluoro-2-deoxy-D-glucose PET scan of the brain in maple syrup urine disease. Clinical Nuclear Medicine 24(8): 612
Buchmann, I.; Reinhardt, M.; Elsner, K.; Bunjes, D.; Altehoefer, C.; Finke, J.; Moser, E.; Glatting, G.; Kotzerke, J.; Guhlmann, C.A.; Schirrmeister, H.; Reske, S.N. 2001: 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Cancer 91(5): 889-899
Niemeyer, T.; Liljenqvist, U.; Halm, H.; Winkelmann, W. 1999: 2-4 Years results of posterior doublerod instrumentation in the treatment of idiopathic scoliosis. Zeitschrift fuer Orthopaedie und ihre Grenzgebiete 137(5): 430-436
Kushner, D.M.; Paranjape, J.M.; Bandyopadhyay, B.; Cramer, H.; Leaman, D.W.; Kennedy, A.W.; Silverman, R.H.; Cowell, J.K. 2000: 2-5A antisense directed against telomerase RNA produces apoptosis in ovarian cancer cells. Gynecologic Oncology 76(2): 183-192
Mukai, S.; Kondo, Y.; Koga, S.; Komata, T.; Barna, B.P.; Kondo, S. 2000: 2-5A antisense telomerase RNA therapy for intracranial malignant gliomas. Cancer Research 60(16): 4461-4467
Barnard, D.L.; Sidwell, R.W.; Xiao, W.; Player, M.R.; Adah, S.A.; Torrence, P.F. 1999: 2-5A-DNA conjugate inhibition of respiratory syncytial virus replication: Effects of oligonucleotide structure modifications and RNA target site selection. Antiviral Research 41(3): 119-134
Verheijen, J.C.; Bayly, S.F.; Player, M.R.; Torrence, P.F.; Van Der Marel, G.A.; Van Boom, J.H. 1999: 2-5A-PNA complexes: A novel class of antisense compounds. Nucleosides and Nucleotides 18(6-7): 1485-1486
Keller, L.; Camara, C.; Pinheiro, A.; Dumas, F.; D'angelo, J. 2001: 2-Acetoxyacrylonitrile: Use as electrophile equivalent to acetaldehyde in the asymmetric Michael reaction using chiral imines. Tetrahedron Letters 42(3): 381-383, 15 January
Manaka, A.; Sato, M.; Aoki, M.; Tanaka, M.; Ikeda, T.; Toda, Y.; Yamane, Y.; Nakaike, S. 2001: 2-Acylimino-3H-thiazoline derivatives: A novel template for platelet GPIIb/IIIa receptor antagonists. Bioorganic and Medicinal Chemistry Letters 11(8): 1031-1035
White, E.L.; Suling, W.J.; Ross, L.J.; Seitz, L.E.; Reynolds, R.C. 2002: 2-Alkoxycarbonylaminopyridines: inhibitors of Mycobacterium tuberculosis FtsZ. Journal of Antimicrobial ChemoTherapy 50(1): 111-114
Yagupolskii, L., M.; Fedyuk, D., V. 2000: 2-Alkyl-1-(2-aryl-1,1-difluoro-2-hydroxyethyl)benzimidazoles: Potential angiotensin II receptor antagonists. Tetrahedron Letters 41(13): 2265-2267
Ouedraogo, R.; Becker, B.én.éd.; Boverie, S.ép.; Somers, F.; Antoine, M.-H.él.èn.; Pirotte, B.; Lebrun, P.; de Tullio, P. 2002: 2-alkyl-3-Alkylamino-2H-Benzo- and pyridothiadiazine 1,1-dioxides: from K+ATP channel openers to Ca++ channel blockers?. Biological Chemistry 383(11): 1759-1768
Ndiaye, B.; Horvatovich, P.; Miesch, M.; Hasselmann, C.; Marchioni, E. 1999: 2-Alkylcyclobutanones as markers for irradiated foodstuffs. III. Improvement of the field of application on the EN 1785 method by using silver ion chromatography. Journal of Chromatography A 858(1): 109-115
Vasiljev, K.S.; Uri, A.; Laitinen, J.T. 2003: 2-Alkylthio-substituted platelet P2Y12 receptor antagonists reveal pharmacological identity between the rat brain Gi-linked ADP receptors and P2Y12. Neuropharmacology 45(1): 145-154
Clerici, F.; Erba, E.; Pocar, D. 2003: 2-Amidinylindole-3-carbaldehydes: Synthesis of new tetracyclic compounds containing the pyrrolo(1,2-c)1,4-diazepine ring. Tetrahedron 59(10): 1667-1671
Erba, E.; Gelmi, M.L.; Pocar, D. 2000: 2-Amidinylindole-3-carbaldehydes: Versatile synthons for the preparation of alpha-carboline derivatives. Tetrahedron 56(51): 9991-9997, 15 December
Venugopal, M.; Callaway, A.; Snyderwine, E., G. 1999: 2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP) retards mammary gland involution in lactating Sprague-Dawley rats. Carcinogenesis (Oxford) 20(7): 1309-1314
Wong, W.C.; Sun, W.; Cui, W.; Chen, Y.; Forray, C.; Vaysse, P.J.; Branchek, T.A.; Gluchowski, C. 2000: 2-amino-2-oxazolines as subtype selective alpha(2) adrenoceptor agonists. Journal of Medicinal Chemistry 43(9): 1699-1704
Tranberg, C.E.; Zickgraf, A.; Giunta, B.N.; Luetjens, H.; Figler, H.; Murphree, L.J.; Falke, R.; Fleischer, H.; Linden, J.; Scammells, P.J.; Olsson, R.A. 2002: 2-Amino-3-aroyl-4,5-alkylthiophenes: agonist allosteric enhancers at human A(1) adenosine receptors. Journal of Medicinal Chemistry 45(2): 382-389
Lütjens, H.; Zickgraf, A.; Figler, H.; Linden, J.; Olsson, R.A.; Scammells, P.J. 2003: 2-Amino-3-benzoylthiophene allosteric enhancers of A1 adenosine agonist binding: new 3, 4-, and 5-modifications. Journal of Medicinal Chemistry 46(10): 1870-1877
Yamamoto, K.; Hamase, K.; Zaitsu, K. 2003: 2-amino-3-phenylpyrazine, a sensitive fluorescence prelabeling reagent for the chromatographic or electrophoretic determination of saccharides. Journal of Chromatography A 1004(1-2): 99-106
Henke, B.R.; Drewry, D.H.; Jones, S.A.; Stewart, E.L.; Weaver, S.L.; Wiethe, R.W. 2001: 2-Amino-4,6-diarylpyridines as novel ligands for the estrogen receptor. Bioorganic and Medicinal Chemistry Letters 11(14): 1939-1942
Li, Y.; Li, Z.; Zhang, S.; Ou, Z. 1998: 2-Amino-5-oxo-2-tetrahydrofuran carboxylic acids, novel gamma-lactone antibacterial agents. Zhongguo Kangshengsu Zazhi 23(5): 336-337, 367
Alarcon, K.; Martelli, A.; Demeunynck, M.; Lhomme, J. 2000: 2-Amino-6-(1,2,4-triazol-4-yl)-purine: A useful intermediate in the synthesis of 9-alkylguanines. Tetrahedron Letters 41(37): 7211-7215
Chan, J.H.; Hong, J.S.; Hunter, R.N.; Orr, G.F.; Cowan, J.R.; Sherman, D.B.; Sparks, S.M.; Reitter, B.E.; Andrews, C.W.; Hazen, R.J.; St Clair, M.; Boone, L.R.; Ferris, R.G.; Creech, K.L.; Roberts, G.B.; Short, S.A.; Weaver, K.; Ott, R.J.; Ren, J.; Hopkins, A.; Stuart, D.I.; Stammers, D.K. 2001: 2-Amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1. Journal of Medicinal Chemistry 44(12): 1866-1882
Okamoto, A.; Tanaka, K.; Saito, I. 2002: 2-Amino-7-deazaadenine forms stable base pairs with cytosine and thymine. Bioorganic and Medicinal Chemistry Letters 12(1): 97-99, 7 January
Tuzun, I.; Karatas, A., Y.; Sesenoglu, O.; Demir, A., S.; Ozcengiz, G. 2003: 2-Amino-N-(2-furylmethyl)propanamide as a novel alanylglycine equivalent synthesized by bacilysin synthetase. Enzyme and Microbial Technology 33(5): 725-728
Servillo, L.; Balestrieri, C.; Boccellino, M.; Balestrieri, M.L.; Quagliuolo, L.; Giovane, A. 1999: 2-aminoanthracene as an analytical tool with the acetylation reaction catalyzed by arylamine N-acetyltransferase. Analytical Biochemistry 273(1): 105-110
Braun, F.-J.; Aziz, O.; Putney, J.W. 2003: 2-aminoethoxydiphenyl borane activates a novel calcium-permeable cation channel. Molecular Pharmacology 63(6): 1304-1311
Peppiatt, C.M.; Collins, T.J.; Mackenzie, L.; Conway, S.J.; Holmes, A.B.; Bootman, M.D.; Berridge, M.J.; Seo, J.T.; Roderick, H.Llewelyn. 2003: 2-Aminoethoxydiphenyl borate (2-APB) antagonises inositol 1,4,5-trisphosphate-induced calcium release, inhibits calcium pumps and has a use-dependent and slowly reversible action on store-operated calcium entry channels. Cell Calcium 34(1): 97-108
Missiaen, L.; Callewaert, G.; De Smedt, H.; Parys, J.B. 2001: 2-Aminoethoxydiphenyl borate affects the inositol 1,4,5-trisphosphate receptor, the intracellular Ca2+ pump and the non-specific Ca2+ leak from the non-mitochondrial Ca2+ stores in permeabilized A7r5 cells. Cell Calcium 29(2): 111-116
Imai, T.; Tanaka, Y.; Okamoto, T.; Horinouchi, T.; Tanaka, H.; Koike, K.; Shigenobu, K. 2002: 2-Aminoethoxydiphenyl borate causes dissociation between membrane electrical and mechanical activity in guinea-pig urinary bladder smooth muscle. Naunyn-Schmiedeberg's Archives of Pharmacology 366(3): 282-285
Dobrydneva, Y.; Blackmore, P. 2001: 2-Aminoethoxydiphenyl borate directly inhibits store-operated calcium entry channels in human platelets. Molecular Pharmacology 60(3): 541-552
Soulsby, M.D.; Wojcikiewicz, R.J.H. 2002: 2-Aminoethoxydiphenyl borate inhibits inositol 1,4,5-trisphosphate receptor function, ubiquitination and downregulation, but acts with variable characteristics in different cell types. Cell Calcium 32(4): 175-181
Wang, Y.; Deshpande, M.; Payne, R. 2002: 2-Aminoethoxydiphenyl borate inhibits phototransduction and blocks voltage-gated potassium channels in Limulus ventral photoreceptors. Cell Calcium 32(4): 209-216
Wu, J.; Kamimura, N.; Takeo, T.; Suga, S.; Wakui, M.; Maruyama, T.; Mikoshiba, K. 2000: 2-Aminoethoxydiphenyl borate modulates kinetics of intracellular Ca(2+) signals mediated by inositol 1,4,5-trisphosphate-sensitive Ca(2+) stores in single pancreatic acinar cells of mouse. Molecular Pharmacology 58(6): 1368-1374
Kukkonen, J.P.; Lund, P.E.; Akerman, K.E. 2001: 2-aminoethoxydiphenyl borate reveals heterogeneity in receptor-activated Ca(2+) discharge and store-operated Ca(2+) influx. Cell Calcium 30(2): 117-129
Jean, J.M.; Hall, K.B. 2002: 2-Aminopurine electronic structure and fluorescence properties in DNA. Biochemistry 41(44): 13152-13161
Balaban, T.S.; Goddard, R.; Linke-Schaetzel, M.; Lehn, J.-M. 2003: 2-Aminopyrimidine directed self-assembly of zinc porphyrins containing bulky 3,5-di-tert-butylphenyl groups. Journal of the American Chemical Society 125(14): 4233-4239
Chordia, M.D.; Murphree, L.J.; Macdonald, T.L.; Linden, J.; Olsson, R.A. 2002: 2-Aminothiazoles: a new class of agonist allosteric enhancers of A(1) adenosine receptors. Bioorganic and Medicinal Chemistry Letters 12(12): 1563-1566
Sugiura, T.; Waku, K. 2000: 2-Arachidonoylglycerol and the cannabinoid receptors. Chemistry and Physics of Lipids 108(1-2): 89-106
Kishimoto, S.; Gokoh, M.; Oka, S.; Muramatsu, M.; Kajiwara, T.; Waku, K.; Sugiura, T. 2003: 2-arachidonoylglycerol induces the migration of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes through the cannabinoid CB2 receptor-dependent mechanism. Journal of Biological Chemistry 278(27): 24469-24475
Kagota, S.; Yamaguchi, Y.; Nakamura, K.; Sugiura, T.; Waku, K.; Kunitomo, M. 2001: 2-Arachidonoylglycerol, a candidate of endothelium-derived hyperpolarizing factor. European Journal of Pharmacology 415(2-3): 233-238
Hanus, L.; Abu-Lafi, S.; Fride, E.; Breuer, A.; Vogel, Z.; Shalev, D.E.; Kustanovich, I.; Mechoulam, R. 2001: 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proceedings of the National Academy of Sciences of the United States of America 98(7): 3662-3665
Stefano, G.B.; Bilfinger, T.V.; Rialas, C.M.; Deutsch, D.G. 2000: 2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1. Pharmacological Research 42(4): 317-322
Gallily, R.; Breuer, A.; Mechoulam, R. 2000: 2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice. European Journal of Pharmacology 406(1): R5-R7
Beckers, T.; Reissmann, T.; Schmidt, M.; Burger, A.M.; Fiebig, H.H.; Vanhoefer, U.; Pongratz, H.; Hufsky, H.; Hockemeyer, J.ör.; Frieser, M.; Mahboobi, S. 2002: 2-aroylindoles, a novel class of potent, orally active small molecule tubulin inhibitors. Cancer Research 62(11): 3113-3119
Shaw, D.; Chicchi, G.G.; Elliott, J.M.; Kurtz, M.; Morrison, D.; Ridgill, M.P.; Szeto, N.; Watt, A.P.; Williams, A.R.; Swain, C.J. 2001: 2-Aryl indole NK(1) antagonists: optimisation of the amide substituent. Bioorganic and Medicinal Chemistry Letters 11(23): 3031-3034
Cooper, L.C.; Chicchi, G.G.; Dinnell, K.; Elliott, J.M.; Hollingworth, G.J.; Kurtz, M.M.; Locker, K.L.; Morrison, D.; Shaw, D.E.; Tsao, K.L.; Watt, A.P.; Williams, A.R.; Swain, C.J. 2001: 2-Aryl indole NK1 receptor antagonists: Optimisation of indole substitution. Bioorganic and Medicinal Chemistry Letters 11(9): 1233-1236
Dinnell, K.; Chicchi, G.G.; Dhar, M.J.; Elliott, J.M.; Hollingworth, G.J.; Kurtz, M.M.; Ridgill, M.P.; Rycroft, W.; Tsao, K.L.; Williams, A.R.; Swain, C.J. 2001: 2-Aryl indole NK1 receptor antagonists: Optimisation of the 2-aryl ring and the indole nitrogen substituent. Bioorganic and Medicinal Chemistry Letters 11(9): 1237-1240
Hodgetts, K.J.; Yoon, T.; Huang, J.; Gulianello, M.; Kieltyka, A.; Primus, R.; Brodbeck, R.; De Lombaert, Séphane.; Doller, Dío. 2003: 2-Aryl-3,6-dialkyl-5-dialkylaminopyrimidin-4-ones as novel CRF-1 receptor antagonists. Bioorganic and Medicinal Chemistry Letters 13(15): 2497-2500
Jeffery, D.; Prager, R., H.; Turner, D.; Dreimanis, M. 2002: 2-Aryl-3-arylaminoisoxazol-5(2H)-ones as sources of indoles and imidazo(1,2-a)pyridines. Tetrahedron 58(50): 9965-9972
Müller, K.; Altmann, R.; Prinz, H. 2001: 2-Arylalkyl-substituted anthracenones as inhibitors of 12-lipoxygenase enzymes. 1. Structure-activity relationships of the terminal aryl ring. European Journal of Medicinal Chemistry 36(6): 569-575
Hodgson, D.M.; Bebbington, M.W.P.; Willis, P. 2002: 2-azabenzonorbornanes from 7-azabenzonorbornanols by a nitrogen-directed neophyl-type radical rearrangement. Organic Letters 4(24): 4353-4356
Dominguez, B., M.; Cullis, P., M. 1999: 2-Azabicyclo(2.2.1)hept-5-en-3-one epoxide: A versatile intermediate for the synthesis of cyclopentyl carbocyclic 2-deoxy-, 3-deoxy- and ara- ribonucleoside analogues. Tetrahedron Letters 40(31): 5783-5786
Easmon, J.; Puerstinger, G.; Roth, T.; Fiebig, H.H.; Jenny, M.; Jaeger, W.; Heinisch, G.; Hofmann, J. 2001: 2-benzoxazolyl and 2-benzimidazolyl hydrazones derived from 2-acetylpyridine: a novel class of antitumor agents. International Journal of Cancer 94(1): 89-96
Park, J.I.; Kim, D.H. 2001: 2-Benzyl-3,4-iminobutanoic acid as inhibitor of carboxypeptidase A. Bioorganic and Medicinal Chemistry Letters 11(22): 2967-2970
Wang, J-Pyang.; Chang, L-Chu.; Hsu, M-Feng.; Huang, L-Jiau.; Kuo, S-Chu. 2002: 2-Benzyloxybenzaldehyde inhibits formyl-methionyl-leucyl-phenylalanine stimulation of phospholipase D activation in rat neutrophils. Biochimica et Biophysica Acta 1573(1): 26-32
Kitade, Y.kio; Wakana, Masaharu; Terai, Shin Ichi; Tsuboi, Takayuki; Nakanishi, Masayuki; Yatome, Chizuko; Dong, Beihua; Silverman, Robert, H.; Torrence, Paul, F. 1998: 2-Bromoadenosine-substituted 2',5'-oligoadenylates modulate binding and activation abilities of human recombinant RNase L. Nucleosides and Nucleotides 17(12): 2323-2333
Chiu, P.C.; Lee, M. 2001: 2-Bromoethanesulfonate affects bacteria in a trichloroethene-dechlorinating culture. Applied and Environmental Microbiology 67(5): 2371-2374
Ye; Quensen; Tiedje; Boyd 1999: 2-Bromoethanesulfonate, sulfate, molybdate, and ethanesulfonate inhibit anaerobic dechlorination of polychlorobiphenyls by pasteurized microorganisms. Applied and Environmental Microbiology 65(1): 327-329
Kinemuchi, H.; Jinbo, M.; Tabata, A.; Toyoshima, Y.; Arai, Y.; Tadano, T.; Kisara, K.; Oreland, L. 2000: 2-Bromoethylamine, a suicide inhibitor of tissue-bound semicarbazide-sensitive amine oxidase. Japanese Journal of Pharmacology 83(2): 164-166
Yu, X.; Kamijima, M.; Ichihara, G.; Li, W.; Kitoh, J.; Xie, Z.; Shibata, E.; Hisanaga, N.; Takeuchi, Y. 1999: 2-Bromopropane causes ovarian dysfunction by damaging primordial follicles and their oocytes in female rats. Toxicology and Applied Pharmacology 159(3): 185-193
Wu, X.; Faqi, A.S.; Yang, J.; Pang, B.Pang.; Ding, X.; Jiang, X.; Chahoud, I. 2002: 2-Bromopropane induces DNA damage, impairs functional antioxidant cellular defenses, and enhances the lipid peroxidation process in primary cultures of rat Leydig cells. Reproductive Toxicology 16(4): 379-384
Koshkaryev, A.; Barshtein, G.; Nyska, A.; Ezov, N.; Levin-Harrus, T.; Shabat, S.; Nyska, M.; Redlich, M.; Tsipis, F.; Yedgar, S. 2003: 2-Butoxyethanol enhances the adherence of red blood cells. Archives of Toxicology 77(8): 465-469
Logothetis, T.A.; Eilitz, U.; Hiller, W.; Burger, K. 1998: 2-C-trifluoromethyl substituted pentoses. Tetrahedron 54(46): 14023-14030
Van Os, J.; Altamura, A.C.; Bobes, J.; Owens, D.C.; Gerlach, J.; Hellewell, J.S.E.; Kasper, S.; Naber, D.; Tarrier, N.; Robert, P. 2002: 2-COM: An instrument to facilitate patient-professional communication in routine clinical practice. Acta Psychiatrica Scandinavica 106(6): 446-452
Teunissen, P.J.; Field, J.A. 1998: 2-Chloro-1,4-dimethoxybenzene as a mediator of lignin peroxidase catalyzed oxidations. FEBS Letters 439(3): 219-223
Teunissen, P.J.; Sheng, D.; Reddy, G.V.; Moënne-Loccoz, P.; Field, J.A.; Gold, M.H. 1998: 2-Chloro-1,4-dimethoxybenzene cation radical: formation and role in the lignin peroxidase oxidation of anisyl alcohol. Archives of Biochemistry and Biophysics 360(2): 233-238
Ertl, P.; Cooper, D.; Allen, G.; Slater, M.J. 1999: 2-Chloro-3-substituted-1,4-naphthoquinone inactivators of human cytomegalovirus protease. Bioorganic and Medicinal Chemistry Letters 9(19): 2863-2866
Gao, Z-guo.; Jacobson, K.A. 2002: 2-Chloro-N(6)-cyclopentyladenosine, adenosine A(1) receptor agonist, antagonizes the adenosine A(3) receptor. European Journal of Pharmacology 443(1-3): 39-42
Khan, G.M.; Smolders, I.; Ebinger, G.; Michotte, Y. 2001: 2-chloro-N(6)-cyclopentyladenosine-elicited attenuation of evoked glutamate release is not sufficient to give complete protection against pilocarpine-induced seizures in rats. Neuropharmacology 40(5): 657-667
Frank, C.; Giammarioli, A.M.; Falzano, L.; Rufini, S.; Ceruti, S.; Camurri, A.; Malorni, W.; Abbracchio, M.P.; Fiorentini, C. 2000: 2-Chloro-adenosine induces a glutamate-dependent calcium response in C2C12 myotubes. Biochemical and Biophysical Research Communications 277(3): 546-551
Zielinski, B.; Hergenhahn, M. 2001: 2-Chloroacetaldehyde induces epsilondA DNA adducts in DNA of Raji cells as demonstrated by an improved HPLC-fluorimetry method. Fresenius' Journal of Analytical Chemistry 370(1): 97-100
Robak, T.; Błasińska-Morawiec, M.; Błoński, J.; Hellmann, A.; Hałaburda, K.; Konopka, L.; Kotlarek-Haus, S.; Potoczek, S.; Hansz, J.; Dmoszyńska, A.; Urasiński, I.; Zdziarska, B.; Dwilewicz-Trojaczek, J.; Hołowiecki, J.; Skotnicki, A.B. 1999: 2-Chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland. European Journal of Haematology 62(1): 49-56
Dialer, H.; Steglich, W.; Beck, W. 2001: 2-Cyclopentadienylglycine, a new alpha-amino acid and its use for eta5-complex formation. Tetrahedron 57(23): 4855-4861, 4 June
Ianaro, A.; Maffia, P.; Cuzzocrea, S.; Mazzon, E.; Santoro, M.G.; Di Rosa, M.; Ialenti, A. 2003: 2-Cyclopenten-1-one and prostaglandin J2 reduce restenosis after balloon angioplasty in rats: role of NF-kappaB. Febs Letters 553(1-2): 21-27
Liu, J.B.; Goldberg, B.B. 1999: 2-D and 3-D endoluminal ultrasound: Vascular and nonvascular applications. Ultrasound in Medicine and Biology 25(2): 159-173
Yang, J.; Cavalcanti, M.G.; Ruprecht, A.; Vannier, M.W. 1999: 2-D and 3-D reconstructions of spiral computed tomography in localization of the inferior alveolar canal for dental implants. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 87(3): 369-374
Wang Shaoqing; Yao Zhi; Chen Yu 2000: 2-D and Doppler ultrasonic appearance of normal human eyes. Xi'an Yike Daxue Xuebao 21(4): 348-350
Liu-Meizhen; Wu-Chun; Jiang-Baoqi 2000: 2-D echocardiography characteristics of acute right ventricle myocardial infarction. Zhongguo Chaosheng Yixue Zazhi 16(9): 675-677
Ilík, P.; Krchnák, P.; Tomek, P.; Naus, J. 2002: 2-D gel densitometer for high-contrast and selective imaging of chlorophyll-containing protein complexes separated by non-denaturing polyacrylamide gel electrophoresis. Journal of Biochemical and Biophysical Methods 51(3): 273-281
Shimizu, H.; Suda, K. 1998: 2-D index as a measure for estimating the complexity degree of 3-D sinusoidal structures in the normal and cirrhotic liver and in hepatocellular carcinoma. Analytical and Quantitative Cytology and Histology 20(6): 526-528
Gilbert, F.; Hulth, S.; Stromberg, N.; Ringdahl, K.; Poggiale, J.C.ristophe 2003: 2-D optical quantification of particle reworking activities in marine surface sediments. Journal of Experimental: 251-263 (Special Issue)
Cheng, R.; Cheng, X.; Yang, H. 1999: 2-DE study of the relationship of the heart function and the ventricular configuration in pulmonary hypertension. Zhongguo Chaosheng Yixue Zazhi 15(1): 38-40
Sarker, S.D.; Sik, V.; Rees, H.H.; Dinan, L. 1998: 2-Dehydro-3-epi-20-hydroxyecdysone from Froelichia florida. Phytochemistry 49(8): 2311-2314
Koshy, M.; Dorn, L.; Bressler, L.; Molokie, R.; Lavelle, D.; Talischy, N.; Hoffman, R.; van Overveld, W.; DeSimone, J. 2000: 2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia. Blood 96(7): 2379-2384
Blanchard, N.; Roush, W.R. 2003: 2-Deoxy-2-iodo-beta-glucopyranosyl fluorides: mild and highly stereoselective glycosyl donors for the synthesis of 2-deoxy-beta-glycosides from beta-hydroxy ketones. Organic Letters 5(1): 81-84
Regnier, M.; Rivera, A.J.; Chen, Y.; Chase, P.B. 2000: 2-deoxy-ATP enhances contractility of rat cardiac muscle. Circulation Research 86(12): 1211-1217
Tariq, M.; Arshaduddin, M.; Biary, N.; Al Moutaery, K.; Al Deeb, S. 2002: 2-Deoxy-D-glucose attenuates harmaline induced tremors in rats. Brain Research 945(2): 212-218
Hervías, I.; Lasheras, B.; Aguirre, N. 2000: 2-Deoxy-D-glucose prevents and nicotinamide potentiates 3, 4-methylenedioxymethamphetamine-induced serotonin neurotoxicity. Journal of Neurochemistry 75(3): 982-990
Tsirigotis, P.; Venetis, E.; Kapsimali, V.; Rontogianni, D.; Varvitsioti, E.; Pappa, V.; Apostolidis, P. 2003: 2-Deoxycoformycin in the treatment of T-large granular lymphocyte leukemia. Leukemia Research 27(9): 865-867
Kunze, I.; Ebneth, M.; Heim, U.; Geiger, M.; Sonnewald, U.; Herbers, K. 2001: 2-Deoxyglucose resistance: A novel selection marker for plant transformation. Molecular Breeding 7(3): 221-227
Jürgens, U.; Ehrenreich, L.; De Lanerolle, N.C. 2002: 2-Deoxyglucose uptake during vocalization in the squirrel monkey brain. Behavioural Brain Research 136(2): 605-610
Krnjević, K.; Zhao, Y.T. 2000: 2-Deoxyglucose-induced long-term potentiation of monosynaptic IPSPs in CA1 hippocampal neurons. Journal of Neurophysiology 83(2): 879-887
Barraja, P.; Diana, P.; Lauria, A.; Almerico, A.Maria.; Dattolo, G.; Cirrincione, G. 2002: 2-Diazoindoles: Building blocks for the synthesis of antineoplastic agents. Farmaco 57(2): 97-100
Ozgener, H.; Yuceer, L. 2002: 2-Dichloromethyl-1,3-dioxolan-2-yl orthoesters. A potential protecting group for sugar derivatives. Journal of Carbohydrate Chemistry 21(6): 559-567
Jizba, J.; Hejdukova, M.; Blumauerova, M.; Ujhelyiova, L.; Varkonda, S. 1998: 2-Epi-homononactic acid: Fermentation, isolation and insecticidal activity. Plant Protection Science 34(3): 87-89
Sicinski, R.R.; Rotkiewicz, P.; Kolinski, A.; Sicinska, W.; Prahl, J.M.; Smith, C.M.; DeLuca, H.F. 2002: 2-Ethyl and 2-ethylidene analogues of 1alpha,25-dihydroxy-19-norvitamin D(3): synthesis, conformational analysis, biological activities, and docking to the modeled rVDR ligand binding domain. Journal of Medicinal Chemistry 45(16): 3366-3380
Earl, R.A.; Zaczek, R.; Teleha, C.A.; Fisher, B.N.; Maciag, C.M.; Marynowski, M.E.; Logue, A.R.; Tam, S.W.; Tinker, W.J.; Huang, S.M.; Chorvat, R.J. 1998: 2-Fluoro-4-pyridinylmethyl analogues of linopirdine as orally active acetylcholine release-enhancing agents with good efficacy and duration of action. Journal of Medicinal Chemistry 41(23): 4615-4622
Gibson, C.; Kessler, H. 2000: 2-Fluoropyrimidine as an efficient reagent in solid-phase synthesis of N-aryl- and N-alkyl-N-pyrimidin-2-ylamines. Tetrahedron Letters 41(11): 1725-1728